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Pig production is an important socio-economic activity in Uganda. Not only does the country have the largest pig 
population in East Africa, it also has the most rapidly growing pig population in sub-Saharan Africa and the highest 
per capita pork consumption in Eastern Africa (FAO, 2011). Taenia solium cysticercosis is a parasitic zoonosis 
caused by larval cysts of pig cestode. Porcine cysticercosis is a faecal-borne infection caused by the ingestion of T. 
solium eggs dispersed by a human T. solium tapeworm carrier. New tools have become available for the control of 
porcine cysticercosis that could help to break the disease cycle (Lightowlers, 2013), namely a recombinant vaccine 
antigen, TSOL18, and the benzimidazole drug oxfendazole, which can act as a de-wormer in pigs. These drugs 
are not currently on the market in Uganda. GALVmed, a product development and adoption partnership focusing 
on	livestock	health,	has	implemented	field	trials	in	Uganda	aimed	at	the	control	of	T. solium through the combined 
use	of	TSOL	18	vaccine	and	oxfendazole.	Results	from	the	trials	have	confirmed	the	efficacy	of	the	combined	use	
of the vaccine and oxfendazole in preventing infection in the pigs enhancing immunity against T. solium (Nsadha 
et	al.,	2021)	Although	the	vaccine	has	proven	effective	during	the	GALVmed	field	trials	in	Uganda,	its	potential	for	
marketing as a private good has not been evaluated. This study addresses this gap by conducting market scoping 
studies to generate evidence to guide the Porcine Cysticercosis vaccine entry into the market in Uganda.
Objectives and methods
The objective of the market scoping study was to assess the potential demand for the TSOL vaccine -oxfendazole 
combination and to gain a clear understanding of its potential for ‘private good’ marketing. It also assesses how 
the	vaccine	might	influence	product	availability,	supply	mechanisms,	price	structure,	competitiveness	of	products,	
profit	margins,	and	the	potential	to	sell	these	products	to	smallholder	pig	producers	in	Uganda.	
Eight separate market scoping studies have been conducted in Uganda’s Masaka, Bukedea, Kampala and 
Mukono	districts	targeted	at	different	nodes	of	the	pig	value	chain	–	namely	consumers,	traders,	distributors,	
and drug stockists – and involved interviews, focus group discussions, a simulated egg experiment, choice 
experiments, and observation. Choice experiment is a multi-trait/multi-attribute stated preference method that 
assesses the value of single traits of a bundled good by using individuals’ stated preference in a hypothetical 
scenario. Due to the hypothetical nature of stated preference data in which the respondents are not bound by real 





• Farmers had a strong preference for a porcine cysticercosis vaccination that would yield them premium 
prices	when	selling	their	pig	and	that	would	only	require	a	single	dose	to	confer	immunity.	Farmers	
indicated willingness to pay US$0.44 more if the vaccine resulted in an additional dollar in price, as well 
as US$1.67 more for a vaccine administered once versus three times. This is a key point that unless 
the pig market system can pay premium price for TSOL18 vaccinated pigs, uptake of the vaccine by 
farmers through market mechanisms may not be successful.
• The choice experiment results showed a low proportion of farmers (only 19%) that selected the 
choice option of the vaccine with its current combination of attributes and were willing to pay a total 
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of US$2.61 for the vaccine per pig (including administration costs) until immunity is attained. Many 
farmers (38 – 50%) selected choice options that had combinations of improved attributes of the 
vaccine especially higher price premium of vaccinated pigs and a vaccine viability detector and were 
willing to pay US$12 – 17.
• Pig traders are aware of porcine cysticercosis, and most trader participants indicated that they refuse 
to	purchase	pigs	suffering	from	porcine	cysticercosis.	However,	results	show	that	traders’	most	
preferred attribute for pigs was weight gain, although they also reported concerns about consumer 
health. Weight gain can be achieved through appropriate deworming regimes such as through use of 
oxfendazole.
• Consumer focus group discussion participants considered hygiene as the most important factor 
in	ensuring	pork	is	safe.	They	also	noted	willingness	to	pay	more	for	pork	certified	to	be	porcine	
cysticercosis-free as long as their safety is guaranteed. However, consumers’ preferences as depicted 
by actual purchases are driven by other factors such as personal preferences versus food safety, and 
they	may	have	a	different	perception	of	what	is	considered	as	‘safe	food’,	as	compared	to	food	safety	
experts.
• There appears to be substantial demand for livestock de-wormers in Uganda, and the market for 
de-wormers is relatively crowded. Animal health service providers preferred ivermectin, while farmers 
preferred levamisole and albendazole. Most other drugs are cheaper per dose than Paranthic 10% 
(active ingredient oxfendazole), which is an important consideration for farmers.
• For the TSOL18 vaccine-oxfendazole combination to be competitive (if viewed simply as a de-wormer), 
it should be priced between US$1.62 and US$6.11, per the drug stockist scoping study. 
• Even though oxfendazole is comparatively expensive, there is an opportunity for it to capture some 
market	share	because	it	is	a	broad-spectrum	de-wormer	on	top	of	being	effective	against	porcine	
cysticercosis. However, the fact that the vaccine and de-wormers are not packaged together makes 
the	combination	unattractive	to	distributors	because	of	anticipated	challenges	in	acquiring	both	
products at the same time when needed.
Conclusions and Recommendations
Insights from the market scoping study shows that obtaining a premium price for immunized pigs is a strong 
incentive for farmers to vaccinate pigs for porcine cysticercosis. Additionally, the demonstrated preference for 
the TSOL18 vaccine with low administration costs (US$0.90 per pig) underscores a communal approach and 
preference	for	a	one-dose	TSOL18	vaccine.	However,	quality	assurance	is	a	concern	for	pig	farmers,	as	expressed	
in their preference for a viability detector; the product manufacturer should take this into account. The TSOL18 
vaccine-oxfendazole combination as presented is less likely to succeed as a private good. In addition, there 
is need for mass sensitisation about the control of T. solium cysticerciosis amongst stakeholders at all levels 
(including veterinarians, farmers, traders, butchers, consumers, animal health service providers, and policymakers). 
Necessary accompanying intervention measures along the value chain would include:
Animal health service providers: They are the major source of information for farmers. So, they represent 
an important channel for information dissemination to farmers. During awareness campaigns, the animal health 
service providers should be involved. They should also be trained in disease recognition and management of 
carcasses	that	are	affected.
Farmers:  The product packaging and cost of the TSOL18 vaccine-oxfendazole combination should be 
addressed	so	that	farmers	can	easily	purchase	it.	Farmers	should	be	sensitised	about	the	effects	of	the	disease	on	
pigs and its public health importance.
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Traders/butchers: this category of actors could be used as an agent of change, because they are highly 
connected to pig farmers and know all trading networks. They also have high awareness about the disease. They 
should	be	trained	on	the	effects	of	the	disease	in	humans	and	policy	regulations	about	the	disease.	
Distributors: They should be supported (ex. subsidised) by the Government to import the product. 
Government should work together with the distributor to make the product accessible to farmers.
Government: A major role should be played by the Government. This includes:
 - Facilitation of product registration and availability is needed. 
 - Market regulation is needed to enable product entry and market growth. 
 - There is a need for government engagement and support to promote the TSOL18 vaccine-oxfendazole 
combination, as well as to lead disease eradication by facilitating product registration and enabling the 
distribution environment by enforcing regulation on disease control.
 - Support mass sensitisation about the control of T. solium cysticerciosis amongst stakeholders at all 
levels (including veterinarians, farmers, traders, butchers, consumers, animal health service providers, and 
policymakers). 
Researchers: there is a need to carry out socioeconomic impacts studies of the disease to generate evidence 
for decision-makers to justify funding support.
A ‘One Health’ approach to sustain disease control and eradication of porcine cysticercosis is needed. There is 
a need to identify key stakeholders for capacity building through training, as well as to establish a ‘One Health’ 
approach – a public-private partnership forum for stakeholder engagement. 
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Summary of findings
• Finding 1: Farmers want a vaccine which will result in a high premium when they sell the pig. Farmers 
indicated willingness to pay US$0.44 more if the vaccine results in an additional dollar premium price. 
Farmers now get US$43 for a pig. With the current vaccine attributes, only 19% of farmers are willing to 
purchase the vaccine and are willing to pay US$2.61 for it.
• Implication: The current pig market structure does not pay premium price for “safe food”. There may be 
need for consumer sensitisation campaigns to enhance appreciation of safe food. 
• Way forward: Studies on demand for vaccinated pigs. Investigate public private partnerships which would 
subsidise the vaccine.
• Finding 2: Farmers prefer a vaccine given only once and indicated willingness to pay US$1.67 more 
compared to one that is administered three times.
• Implication: The current vaccine needs to be given two times which will be a considerable barrier to uptake.
• Way forward: Further development of the vaccine as a single dose immunisation is needed to make it more 
cost-effective.
• Finding 3. Farmers prefer the inclusion of a vaccine viability detector. Farmers indicated a willingness to pay 
US$4 if the vaccine comes with a viability detector.
• Implication:	This	reflects	concern	over	fraudulent	and	ineffective	products	which	farmers	believe	are	
widespread.
• Way forward: Investigate cost of adding viability indicator. Plan how to proactively build farmer trust in drug 
distribution system.
• Finding 4: The farmers preferred a vaccine associated with low administrative costs.
• Implications: The high cost for vaccine administration may be a disincentive for vaccine uptake
• Way forward: Cheaper models for delivering vaccines to famers should be investigated (ex. promotion of 
group vaccination to reduce on the cost) 
• Finding 5: There are few vaccines for smallholder pig diseases on the market in Uganda
• Implication:	The	TSOL18	vaccine	has	a	high	potential	for	being	the	first	vaccine	introduced	in	the	pig	sector	
in Uganda 
• Way forward: Large sensitization campaign is needed among pig value chain stakeholder to support and 
promote the uptake of the vaccine 
• Finding 6: Albendazole and Erafen 5 (active ingredient fenbendazole) are the potential competitors for 
oxfendazole.
• Implication: It will be very hard for oxfendazole to enter and capture market shares for pig deworming
• Way forward: Entry of oxfendazole in the market should be accompanied by a lot of advertisement to show 
the competitive advantage of oxfendazole as compared to the potential competing products
• Finding 7: Farmers are the main market segment for dewormers 
• Implication: The 1 litre package of oxfendazole would not suit farmers
• Way forward: A smaller packing size of oxfendazole (ex. 10 ml) would be more suited
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2. Smallholder pig value chains in 
Uganda: An introduction
2.1 Pig production demographics
Uganda has the largest pig population in East Africa and the most rapidly growing pig population in sub-Saharan 
Africa. Pig production grew from just 16,000 animals in 1961 to more than 3 million in 2011; while pork accounted 
for only 1 to 2% of the 11 to 12 kilograms per year per capita meat consumption in the 1960s, it now accounts for 
at least one-third of the current 10 kilograms per year. Uganda has the highest per capita consumption in Eastern 
Africa, at 3.4 kilograms per year – almost two times higher than all other East African countries – and the highest 
in sub-Saharan Africa, including South Africa (FAO, 2011) . Moreover, whereas the consumption of pork in Uganda 
sharply increased just before 1990, the consumption of beef has declined; in 2007, they reached the same level 
(figure	1).	
The net result has been that per capita meat consumption in Uganda has remained at a low level of 10 to 11 
kilograms per year, yet meat consumption in developing countries has been continuously increasing from a modest 
average annual per capita consumption of 10 kilograms in the 1960s to 26 kilograms in 2000; it is expected to 
reach	37	kilograms	by	about	2030	(FAO,	2011).	Cattle	and	pig	populations	increased	significantly	from	1970	to	
2010,	according	to	the	records	of	the	Food	and	Agriculture	Organization	of	the	United	Nations	(figure	2).	The	
Uganda Bureau of Statistics found a 4% increase in the country’s pig population from 2010 to 2014 (3.4 to 
3.5	million)	(figure	3).	The	proportion	of	female-headed	households	owning	pigs	in	Uganda	has	also	increased	
significantly	in	the	last	10	years,	from	15%	to	32%,	whereas	the	male-headed	households	with	pigs	have	increased	
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Figure 1: Dynamics of per capita consumption of pork and beef in Uganda 
and Eastern Africa as a whole between 1970 and 2007 (FAOSTAT, 2010)
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Figure 2: Changes in the cattle and pig populations in Uganda between 1970 and 2010 (FAOSTAT, 2010)
2.2 Importance of pig keeping
In	Uganda,	pigs	are	predominantly	kept	by	poor	people	because	pig	keeping	offers	an	attractive	alternative	to	






























Figure 3: Changes in Uganda’s pig population between 1991 and 2008 (UBOS, 2009)
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2.3 Pig population density and geographic distribution
The	majority	of	pigs	in	Uganda	are	located	in	the	central	region,	as	shown	in	figures	4	and	5.	Masaka,	Wakiso,	and	
Mukono districts have the highest pig population density in the country. The northern part of the country has low 
pig population density, with Nakapipirit and Koboko having the lowest pig population (Annex 1).
Figure 4: Pig population density in Uganda (Ouma et al., 2015)




















Figure 5: Pig population by region in Uganda (UBOS)
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2.4 Pig production systems




slaughter. Typical smallholder farmers, including piglet producers and growers, comprise about 80% of households 
in the studied regions in Uganda – Masaka, Mukono, Kamuli, Lira, and Hoima (Ouma et al., 2015)
2.4.2 Pig Keeping systems
Three	keeping	systems	are	practiced	in	Uganda:	free-range	or	scavenging	(extensive),	confinement	or	housing	
(intensive), and tethering. Pig keeping types can vary according to the season, with farmers tending to practice 
extensive systems more during the dry season (compared to the rainy season), when most of the gardens have 
been harvested and pigs scavenge for plant remains or crop residue. This is in part because the crossed and 
exotic breeds are feared to contract diseases and succumb to environmental pressure when they roam (unlike the 
indigenous breeds, which are perceived as resistant). Extensive pig-keeping relieves farmers of the need to collect 
or	purchase	feeds,	as	it	is	assumed	that	the	pigs	find	adequate	food	and	sufficient	nutrients	through	scavenging.	It	
also allows sows to access breeding boars within the system when farmers do not have their own boars or enough 
money to pay for breeding.
Tethering	usually	involves	pigs	grazing	in	the	field	in	the	morning	and	later	in	the	day	being	tethered	inside	
compounds	or	very	close	to	homestead,	where	they	have	easy	access	to	crop/plant	residues,	sufficient	water,	
and assured shade. Tethering is the most practiced system in rural areas, with approximately 62% of rural farmers 
Free ranging pig in Masaka, Uganda
(Picture credit/Michel Dione, ILRI)
Confined sow in Masaka, Uganda (Picture credit/Michel Dione, ILRI) Tethered pig in Masaka, Uganda (Picture credit/Michel Dione, ILRI)
15
participating	in	the	study	practicing	it.	Farmers	using	this	technique	indicated	that	small	land	does	not	allow	
animals to scavenge and that lack of funds to construct pig corrals or purchase feeds was the main reason they 




86% of farmers participating in the study reporting their households practiced it. Free-range was reported to be 
more common in rural areas, and mainly seasonal, being more common during dry season (Nantima et al., 2015).
2.4.3 Pig husbandry practices
The pig husbandry practices typically used by Ugandan farmers include castration, deworming, iron injection, 
parasite control, vitamin administration, sow serving, and ear tagging. Farmers are generally responsible for all 
husbandry	practices;	they	engage	with	para-veterinarians	for	specific	services,	mostly	those	that	require	high-level	
skills such as drug injection and castration. The most common disease prevention measure adopted by farmers is 
deworming and parasite control, including spraying pigs with acaricides to control mange; multiple studies report 
the average proportion of farmers who annually deworm their animals is 80%, with farmers deworming an average 
of two times before the pigs are sold or slaughtered(Dione et al., 2014; Ouma et al., 2015). The most common 
dewormers reported by stockists participating in the study to be used by farmers are albendazole and ivermectin. 
Para-veterinarians and drug stockists are the main sources of the drugs, and the cost of the service varies with the 
age of pigs. Piglets cost UGX300 to UGX500 (US$0.08 to US$0.10), while adult pigs cost UGX800 to UGX1,000 
(US$0.20 to US$0.30) per treatment. A few farmers prefer to pay veterinarians for a year’s worth of service, which 
can cost up to UGX50,000 or US$14. Additionally, farmers sometimes deworm by themselves or assist each 
other to lower the cost. This leads to high levels of self-medication, which was reported by farmers to be a major 
problem. (Dione et al., 2014; Opio et al., 2015). 
2.4.4 Pig disease burden 
African swine fever is the most feared pig disease among Ugandan farmers (Dione et al., 2014; Opio et al., 2015; 
Ouma et al., 2015). African swine fever outbreaks have been linked to a strong negative impact on pig farmers’ 
socioeconomic status, involving losing revenue and experiencing more severe poverty (Muhanguzi et al., 2012; Dione 
et al., 2014; Nantima et al., 2016). The disease is recognised as one of the biggest hurdle for the development of 
Uganda’s	pig	sector	(Chenais	et	al.,	2015;	Chenais	et	al.,	2017).	Lack	of	sufficient	knowledge	on	how	to	control	
African	swine	fever,	coupled	with	high-risk	practices	and	the	absence	of	effective	prevention	and	management	
strategies, has resulted in continuous outbreaks of the disease (Ssewaya, 2003). Empowering value chain actors to 
better prevent and respond to African swine fever in a sustainable and realistic manner is key to reducing the disease 
burden	in	domestic	pigs	and	protecting	unaffected	areas	(Dione	et	al.,	2016d;	Nantima	et	al.,	2016).	
Infection with gastrointestinal parasites is also common for smallholder pig farms in Uganda. Almost two-thirds of 




against pathogens such as African swine fever and respiratory pathogens (Dietze et al., 2012). In Uganda 
generally, there is a high prevalence of Streptococcus suis and Leptospira spp., as well as a range of respiratory 
pathogens such as porcine circovirus type 2, Actinobacillus pleuropneumoniae, Mycoplasma hyopneumoniae, 
Influenza	A	and	porcine	parvovirus	(Dione	et	al.,	2018).	Several	zoonotic	pathogens	have	been	detected	in	the	
pig value chain: cysticercosis (Waiswa et al., 2009; Nsadha et al., 2014; Kungu et al., 2017c; Kungu et al., 
2017b), trypanosomosis, trichinellosis, salmonellosis, toxoplasmosis, and erysipelosis (Roesel et al., 2016). 
Observed patterns of multiple infections, related risk factors, biosecurity perceptions, and farmers’ practices 
provide important entry points to improve production systems and reduce the economic impact of common pig 
pathogens. The few existing disease surveillance activities are usually limited to body temperature checks and 
parasite control carried out by farmers themselves and village veterinarians. Additionally, information-sharing 
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platforms in the villages are almost non-existent (Dione et al., 2016c). There is need to reinforce pig disease 
surveillance and control mechanisms in Uganda to reduce the impacts of diseases. 
2.4.5 Animal health service suppliers
According to Ouma et al. (2015) most veterinary drug sellers in 3 major pig producing districts namely Masaka, 
Mukono, and Kamuli are male (72%), and the majority (54%) hold a diploma in animal production. Almost all 
(99%) provide services in addition to selling drugs including treatment, consultation services, and the sale of farm 
equipment.	Dewormers	are	the	most	sold	drugs	by	stockists	(93%),	followed	by	antibiotics	(4%)	and	multivitamins	
(3%). The most used dewormers by farmers are albendazole (46%) and ivermectin (40%). Levamisole, 
praziquantel,	and	piperazine	are	also	used.	Drug	stockists	claimed	that	the	main	causes	of	drug	ineffectiveness	are	
related to the large proportion of farmers medicating on their own, leading to wrong dosage due to poor dilution of 
drugs, poor administration, and poor handling and storage.
The majority of animal health service suppliers are para-veterinarians. They usually hold a diploma in animal 
husbandry	or	a	certificate	in	agriculture	or	livestock.	Only	5%	hold	at	least	a	bachelor’s	degree	in	animal	health,	
e.g., a bachelor’s degree in veterinary medicine. The main services provided by the veterinarians and para-
veterinarians are treatments and advisory services, and almost all (97%) carry out secondary activities such as 
the sale of animal feed, crop production, or breeding services. Advisory services include training farmers in pig 
business management (Dione et al., 2014a).
2.5 Marketing and value chain governance
The major pig related products traded in Uganda are live pigs and pork. Traders play the dominant marketing role 
in the value chain, and they take on multiple roles – essentially, a ‘pig trader’ in this context searches for the pigs, 
bargains with the producer or another trader, buys live pigs, and transports them to where they will be slaughtered. 
Traders will generally either use a motorcycle or bicycle or a truck. If traders are from within the village, they mostly 
use a bicycle or trek with the pig; if they are from outside the village or district, they often use a motorcycle to 
gather the pigs in one central place in the village and transport them using a truck. After slaughter, the traders sell 
the	pork	either	roasted/fried	or	raw	to	the	final	consumer	or	another	trader.	Smallholder	pig	farmers	have	three	
major channels through which they sell their pigs: pork butchers within the village, pork butchers near urban 
centres, and traders coming from Kampala. The channel most available to the farmers is through pork butchers 
within the village (Lule, 2014).
In terms of value chain governance, there are no contractual arrangements between actors in smallholder pig value 
chains. Farmers and traders do not have contracts with buyers or suppliers in all three districts. However, most 
live pig traders are vertically integrated, performing several functions in the value chain under single ownership. 
Pig being transported to the market, Mukono, Uganda (Picture credit/Michel Dione, ILRI)
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Compared to pig farmers who are largely concentrated at the production node, live pig traders are also involved in 
the retail nodes of the value chain, operating pork butcheries and pork joints while also carrying out pig slaughter 
functions (Ouma et al., 2017).
2.6 Animal health service delivery and extension services
In	Masaka,	Lira	and	Mukono	districts,	pig	farmers	identified	various	sources	of	animal	health	services,	including	
veterinarians	employed	by	the	government	such	as	former	National	Advisory	Agricultural	Services	staff	members,	
private veterinarians and animal health workers (para-veterinarians), and experienced farmers who help fellow 
farmers with basic animal health services. Private animal health service providers are the most accessed source 
of services; access to radio programmes (talks show on issues related to crops and livestock) are one source of 
extension services (Ouma et al., 2017) . Most agro-vet business operators among the interviewed population in 
Masaka,	Lira	and	Mukono	(21/36)	hold	diplomas	in	animal	husbandry	and	do	not	have	specific	training	in	animal	
health	(Opio	et	al.,	2015;	Ouma	et	al.,	2015).	Therefore,	substantial	efforts	to	enhance	their	capacities	in	animal	
health would improve livestock health care in Uganda. Additionally, from this study, a higher proportion of men 
received animal health services compared to women except in urban settings.
2.7 Gender and pig production
In Uganda, most pig producer households are male headed (81%). The female spouse often plays a major role in 
initiating	pig	production	through	purchasing	first	stock	in	male-headed	households.	In	terms	of	production,	men	
and women divide up tasks. Men often build the pigsties and to some extent work on the animals’ health and 
husbandry, while women take care of the pigs (e.g., clean the sties, mix feed, and bring water for the animals). 
Sometimes,	women	also	take	on	non-traditional	roles	that	require	knowledge	of	animal	health	and	husbandry	
(Dione et al., 2014a); this happens, for example, during outbreaks of diseases like African swine fever. However, 
men largely dominate other components of the pig value chain, including working as drug stockists, livestock feed 
stockists, live pig traders, and in agro-veterinary services and village boar-keeping businesses.
According to recent study examining gender roles in the pig value chain in Uganda, (Ouma et al., 2016) decision-
making in the pig enterprise in general, women claimed that they exclusively did most of the activities and 
decisions. Men claimed that most activities and decision-making were of shared responsibility or done jointly by 
men and women. Activities clearly in the women’s domain included pig feeding, watering, and cleaning pens; 
marketing was mainly in the men’s domain. In urban areas, most women indicated the enterprise was theirs and 
consequently	it	was	their	role	to	carry	out	activities	and	make	most	decisions	(Dione	et	al.,	2016).	The	study	found	
that men were more knowledgeable and skilled in pig husbandry. This is because they have more ties to outside 
organisations,	interact	more	often	with	veterinary	services	(whose	staff	are	mostly	men),	are	offered	more	training,	
and have greater access to the media and thus to messages about the disease. Men usually can easily interact 
outside the household and access health inputs more easily than women (Ouma et al., 2015). Given the critical 
roles that women play in pig management, there is a need to engage them while implementing interventions aiming 
to upgrade the pig value chain.
2.8 Pig slaughter and pork consumption
There is a lack of designated slaughter facilities for pigs in Uganda in both rural and urban areas, except for 
Kampala.	This	gap	is	filled	by	traders	who	invest	in	backyard	slaughter	facilities	that	are	not	regulated	and	lack	
ante-mortem inspection of pigs. The resulting pork is largely not inspected and mainly sold through local retail 
outlets such as butcheries and pork joints (Ouma et al. 2015). Furthermore, the hygiene of the backyard slaughter 
premises and pork joints, in addition to pork handling, are often poor (Tatwangire, 2014). The veterinary and public 
health departments in local governments are responsible for regulating such premises and enforcing standards to 
ensure	that	only	safe,	high-quality	pork	and	other	meat	products	are	offered	in	the	market.	However,	there	is	poor	
enforcement of these regulations. A study carried out in 158 pork-eating places in Kampala reported that 68% of 
the pork consumed was from places where slaughter was not authorised and meat inspection not carried out, with 
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only	42%	of	the	outlet	owners	having	a	public	health	certificate	to	operate;	holding	a	public	health	certificate	is	an	
important predictor of good practices (Kungu et al., 2017a).
2.9 Pig value chain’s constraints
2.9.1 Production level
The	production	and	management	of	pigs	is	affected	by	a	lack	of	organisational	strategies	to	achieve	economies	
of scale at the farm level (Ouma et al., 2017). Productivity is very low and is largely attributed to the dominance of 
low-input/low-output systems practiced by small-scale producers. The following constraints have been reported 
by several studies: feed shortages during the dry season; poor pig health management resulting from diseases 
such as African swine fever, helminthiasis (such as porcine cysticercosis), and external parasite infestation; poor 
feeding	practices	and	poor	quality	of	feeds;	poor	husbandry	practices;	and	an	absence	of	appropriate	breeding	




(Dione et al., 2014a; Nabikyu and Kugonza, 2016). In addition, regulations on biosecurity measures and waste 
management are poorly implemented, and the adherence of farmers and other actors to these regulations is 
equally	limited	(Ouma	et	al.,	2017)	.	Poor	implementation	of	regulations	results	in	negative	environmental	impacts	
and the spread of diseases.
2.9.2 Health input supply level
Unavailability of inputs and veterinary services are among the most notable constraints to the pig value chain, 
and	the	poor	quality	of	services	and	price	fluctuations	of	these	inputs	are	priority	concerns.	Farmers	claimed	




Carcass of pig hanged at the slaughter
slab, Masaka, Uganda
(Picture credit/Michel Dione, ILRI)
Ready to eat roasted pork, Masaka, Uganda (Picture credit/
Michel Dione, ILRI)
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versions of the same brand of drug by some farmers and drug stockists is a major challenge. The major constraint 
faced in terms of veterinary services is the poor infrastructure, including roads, and poor access to vet service. 
Other	studies	such	as	Ilukor	et	al	(2013)	find	farmer	inability	to	pay	for	quality	veterinary	products	and	services.	
Drug misuse by farmers and service providers was also cited as an important constraint; this practice is associated 
with lack of knowledge of farmers together with low education levels of drug stockists and animal health workers – 
especially the use of poorly trained animal health workers (Ouma et al., 2015).
2.9.3 Trading/Marketing
There are limited pig sales outlet options for farmers, especially in rural areas due to poor linkages with pig buyers 
and	poor	information	flow	(Ouma	et	al.,	2017).	As	a	result,	farmers	are	exposed	to	low	price	offers	for	their	animals	
as they sell their pigs individually to traders and lack bargaining power. Pig farmers within the same locality tend to 
sell their pigs to the same (local) buyers, leading to a glut in the pig market (especially just before schools reopen), 
and further depressing market prices. In addition, farmers have limited capacity in estimation of live weight of pigs 
and	are	therefore	unable	to	assess	whether	price	offers	are	fair	(Ouma	et	al.,	2017)	.	Marketing	is	mostly	done	by	
itinerant	traders	through	brokers	located	in	the	villages.	There	are	no	fixed-point	pig	collection	centres	due	to	lack	
of marketing infrastructure and poor value chain coordination. Such capacity gaps and market disincentives, limits 
farmer investment into the enterprise.
2.9.4 Quality control
Quality assurance standards in the pig production process have yet to be embraced since few traders grade 
pork	products	and	quality	standards	do	not	exist	in	Uganda.	There	is	a	challenge	in	enforcing	existing	rules	and	
regulations in the feed, live pig, pork, and veterinary drug businesses because traders and service providers still 
operate without following government regulations. For example, rules that some businesses do not adhere to 
include	having	inspection	certificates,	business	licenses,	health	examination	certificates,	slaughtering	permits,	or	
animal movement permits (Ouma et al., 2015).
2.9.5 Policy
Although	the	pig	sector	has	significant	potential	in	Uganda	both	commercially	and	as	a	pathway	towards	
poverty reduction, the sector has been marginalised due to its low priority in the national agricultural sector 
policy framework (the Development Strategy and Investment Plan). Pig-raising was not chosen to be among the 
12 priority strategic commodities, although it was recognised as very important for the population’s food and 
nutrition security. According to a stakeholder meeting held in Kampala in 2013, the main underlying cause for 
the government to not prioritise the pig sector is lack of evidence of the industry’s full scope and potential and 
misconceptions about pigs being dirty animals (Worsley, 2013). However, some districts such Hoima and Masaka 
have	prioritised	the	pig	sector	in	their	district	development	plans	and	are	leveraging	different	partners’	work	to	




strategies to harmonise the way actors in smallholder pig value chains are governed. The lack of organisation 
of	farmers,	traders,	processors,	and	other	actors	in	the	value	chain	creates	inefficiencies	that	open	the	door	for	
exploitation	and	poor-quality	products.	There	is	a	need	for	a	good	policy	if	actors,	particularly	pig	farmers,	are	to	
move up the value chain (CGIAR, 2013).
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3. Porcine cysticercosis in Uganda: 
Background and status
T. solium cysticercosis is a parasitic zoonosis caused by larval cysts of pig cestode. The primary intermediate host 
is	the	pig	(which	harbours	the	cysticercal	stage),	with	the	only	definitive	natural	host	being	humans	(who	become	
infected via the adult intestinal tapeworm). Humans can also harbour the cystic stage in their tissue, causing 
cysticercosis or – if located in the central nervous system –neurocysticercosis. Neurocysticercosis is the most 
serious form of cysticercosis in humans and causes epilepsy. Porcine cysticercosis is a faecal-borne infection 
caused by the ingestion of T. solium eggs dispersed by a human T. solium tapeworm carrier. T. solium has received 
little attention for decades despite its traumatising health and socioeconomic impacts (Tatwangire, 2014). 
In many areas in which it is endemic, T. solium	cysticercosis	is	inadequately	controlled	by	the	existing	sanitary	
systems, resulting in considerable public health impact. It remains a major public health problem in developing 
and some developed countries (Boa et al., 2006; Pondja et al., 2012). However, despite the numerous, often 
obvious, and seemingly simple options for preventing T. solium transmission, few intervention programmes have 
led to sustained reduction in the incidence of the disease. Considering the life cycle of T. solium, there are many 
opportunities for controlling the parasite’s transmission.
T. solium cysticercosis is largely under-recognised in many developing countries (Lightowlers, 2013). In Uganda, 
few studies have explored the epidemiology of the disease. Most studies have been limited to reporting prevalence 
and are factor-associated data. Very few studies have addressed the disease from the human health perspective.
3.1 Prevalence and risk factors of porcine cysticercosis in Uganda
Porcine cysticercosis has been reported in Uganda in several studies: 
• High seroprevalence was reported in slaughter slabs in Moyo district (37.7%) (Tsang and Wilson, 
1995). 
• Post-mortem surveys at Wambizi slaughterhouse found a prevalence of 9.4% (Anyanzo, 1999). 
• A	field	survey	reported	the	highest	prevalence	of	porcine	cysticercosis	in	the	Lac	Kyoga	bassin,	with	an	
average	of	24%	in	five	districts	(Kisakye	and	Masaba,	2002).	
• The disease was reported in area of high pig density such as Masaka (11.7%), Kamuli (13.5%), and 
Mukono (11.2%) (Nsadha et al., 2010). 
• Other regions with lower prevalence include Lira (6.5%) and Moyo (13.2%) (Kungu et al., 2018) .
Cysts seen in the masseter muscle of a pig (Picture credit/
Zachary Nsadha, ILRI)
Cyst seen on the tongue of a pig (Picture credit/Zachary 
Nsadha, ILRI)
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Major risk factors are free-range piggery systems, the absence of latrines, and a lack of knowledge amongst pig 
farmers about the disease’s impact in Uganda(Kungu et al., 2019) . Open-air defecation is common in many parts 
of Uganda, and some studies have shown that many households do not have latrines. In Soroti District, 54% of 
households were reported to not have latrines (Kungu et al., 2017b), while 36% of households had no latrines in 
the Lake Kyoga basin. Proper disposal of human faeces is needed in most of these areas. In addition, wrong or 
poor perceptions about the disease in pigs prevent communities from self-evaluating pork for cysticercosis before 
consumption. Ignorance about the transmission of T. solium cysticercosis prevents the adoption of proper control 
measures (Nsadha et al., 2010).
Veterinary inspection of live pig and pork to identify cysts is lacking at both markets and slaughter slabs in most 
districts. The few time it is done for live pigs, it is limited to lingual screening, which is known to have low sensitivity. 
Regular pork inspection in Uganda is only carried out at the country’s only regulated pig slaughterhouse at 
Wambizi, which mainly supplies the urban and peri-urban areas of Kampala (Nsadha, 2013; Kungu et al., 2017a). 
Most	of	the	pork	consumed	in	rural	areas	is	not	inspected	–	for	example,	a	field	study	in	the	Lake	Kyoga	basin	
found 90% of the pork consumed undergoes no inspection (Nsadha, 2013). This is mainly because slaughter is 
carried	out	in	unregistered	places,	making	it	difficult	for	inspection	personnel	to	access	the	sites.
Practices such as open-air defecation and lack of inspection are key contributors to the persistence of porcine 
cysticercosis in Uganda. However, prevalence studies need to be extended to other districts in order to have a 
clearer picture of the distribution of the disease.
3.2 Human health perspectives on porcine cysticercosis
Approximately 2.5 million people worldwide carry the T. solium tapeworm, and at least 20 million people are 
infected with T. solium cysticerci (Nsadha et al., 2010). Neurocysticercosis represents the most common helminthic 
infection of the central nervous system and is one of the most important causes of secondary epilepsy worldwide. 
Conservative estimates attribute 50,000 deaths every year to neurocysticercosis (Bern et al., 1999). The World 
Health Organization estimates that eight people per 1,000 worldwide have neurocysticercosis (Mafojane et al., 
2003), and the disease can lead to epilepsy, severe mental illness, blindness, and death. The disease is reported 
to cause 20 to 50% of all late-onset epilepsy cases globally and is also assumed to be a common cause of 
juvenile epilepsy in certain parts of the world, in particular southern Africa (Phiri et al., 2003). In Uganda, T. solium 
cysticercosis	in	humans	has	been	confirmed	(Winkler,	2012);	however,	there	is	a	lack	of	evidence	of	T. solium as 
cause of neurocysticercosis.
In	some	sub-Saharan	African	countries	(such	as	Nigeria),	the	prevalence	of	human	taeniosis	is	quite	high	(8.6%).	
Surprisingly, however, no cases of human cysticercosis have been reported, although epilepsy is very common. 
Large epidemiological surveys have only been carried out in Togo and Benin, where the prevalence of human 
cysticercosis was 2.4% and 1.3%, respectively. In Central Africa, human cysticercosis is endemic in Rwanda, 
Burundi, the Democratic Republic of the Congo, and Cameroon. Cysticercosis has been shown to be one of the 
major	causes	of	epilepsy	in	Cameroon,	with	figures	as	high	as	44.6%	(Willingham	and	Angels,	2006).	
Based on the available information, a conservative rough economic estimate indicates that the annual monetary 
losses due to porcine cysticercosis in ten western and central African countries amount to about EUR25 million 
(Zoli et al., 2003). In countries where this condition occurs, every case of cysticercosis in pigs has been estimated 
to result in an average loss of EUR194 and nine disability adjusted life years (DALYs) per 1,000 persons per year 
(Zoli	et	al.,	2003).	Financial	losses	due	to	human	cysticercosis	are	very	difficult	to	estimate,	but	they	are	certainly	
exceeded by the social impact of the disease, especially because of the negative perception of epilepsy in many 
African communities. In addition, it is important to note that the true prevalence of T. solium cysticercosis in pigs 
and humans in central and west Africa remains underestimated because of unreliable slaughterhouse data and the 
lack of awareness and diagnostic facilities in the public health sector (Ngowi et al., 2003).
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3.3 Control measures for porcine cysticercosis
 
The eradication of T. solium from most European countries was due to progress in environmental sanitation, 
adequate	husbandry	of	pigs,	and	adequate	inspection	of	pig	carcasses.	Unfortunately,	these	measures	have	
not yet been completely implemented in many developing countries (Zoli et al., 2003). Porcine cysticercosis is 
potentially eradicable for several reasons:
• The adult T. solium lives exclusively in human beings.
• Taeniosis is the only source of infection for the intermediate host. 
• Porcine cysticercosis can be controlled.
• There are no wild reservoirs. 
• There	are	safe	and	efficient	cestocidal	products	against	the	tapeworm	and	the	cysticercus	(Flisser	et	
al., 2003). 
Recently, much progress has been made in terms of research on diagnosis, treatment, and prevention of human 
taeniasis and porcine cysticercosis, although more operational research is still needed. Major obstacles to practical 
implementation of control measures include low levels of sanitation and health education amongst endemic 
populations,	ineffective	health	services	infrastructure,	and	inadequate	socioeconomic	development	in	these	areas	
(Schantz et al., 1993).
Pawlowski et al. (2005) showed the mass drug administration in humans and pigs interrupted transmission of 
taeniasis and cysticercosis in a region in which these diseases were endemic. However, the magnitude of the 
effect	was	small	and	did	not	attain	the	goal	of	eliminating	transmission.	According	to	Garcia	et	al.	(2016),	mass	
drug administration is a temporary solution since unhealthy conditions and poverty prevail in countries where 
these diseases are endemic, making this approach unsustainable; this means that the eradication of taeniasis and 
cysticercosis	requires	a	socioeconomic	and	political	approach,	not	an	entirely	pharmacological	one.	Most	previous	
studies that aimed at controlling porcine cysticercosis did not target regional elimination but rather assessed 
control interventions in a few villages (Carpio et al., 2016). There is a need to validate these studies in wider 
geographical locations.
Eventual elimination of T. solium	taeniasis-cysticercosis	will	benefit	from	the	use	of	a	‘One	Health’	approach	
recognising the connections between human and animal health, with implementation of multiple interventions in 
human, animal, and ecosystem health simultaneously occurring across sectors and supported by appropriate 
health education tools (Garcia et al., 2006; O’Neal et al., 2014). Based on a T. solium cysticercosis transmission 
model (Johansen et al., 2014) and on the available evidence in the literature, the World Health Organization 
recommends a combined approach as the current ‘best-bet’ option for rapid reduction of infection pressure – 
utilising the treatment of human taeniasis cases through mass drug administration or selective chemotherapy 
combined with the TSOL18 vaccination and treatment of the porcine host (oxfendazole, 30mg/kg). This core 
approach should be supplemented by supporting measures such as health education and followed with measures 
requiring	fundamental	social	changes	such	as	improved	meat	inspection,	husbandry,	and	sanitation	(Kyvsgaard	et	
al., 2007). Full community commitment of policymakers and communities will be essential to achieve successful, 
sustainable disease control.
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New tools have become available for controlling porcine cysticercosis that could help break the disease cycle 
(World Health Organization, 2015). T. solium parasites encysted in the muscle tissues of pigs are killed following 
a single oral treatment of 30 mg/kg of the benzimidazole drug oxfendazole (Gonzales et al., 1996). In 2013, 
oxfendazole	manufactured	under	Good	Manufacturing	Practice	standards	was	licensed	for	the	first	time	for	use	
in pigs to treat cysticercosis by MCI Santé Animale, Morocco. Vaccines have also been developed for porcine 
cysticercosis(Flisser et al., 2004). A recombinant vaccine antigen, TSOL18, produced in Escherichia coli has 
been	shown	to	be	highly	effective	at	reducing	T. solium	pig	infections	under	field	conditions	in	Africa	and	Peru	
(Garcia et al., 2016); A commercial vaccine based on TSOL18, and produced under Good Manufacturing Practice 
standards, was licensed in 2016 by Indian Immunologicals Limited, India. These tools provide opportunities for 
new interventions against T. solium.
TSOL18 and oxfendazole
TSOL18 vaccine (Cysvax™): Containing the T. solium oncosphere antigen (TSOL18), 150 ug/ml adjuvanted 
with mineral oil. Dose of 1 ml per pig was administered by intramuscular injection at three-month intervals.
Oxfendazole (Paranthic™ 10%): Containing 10% w/v oxfendazole, oral suspension. Dosage of 3 ml/10kg 
body weight (30 mg/kg) was administered orally. 
• The	TSOL18	vaccine	is	effective	when	both	primary	and	booster	vaccines	are	applied.
• Primary vaccination is given to pigs at least 2 months old.
• Booster vaccine can be given from three weeks to four months after the primary vaccine. Immunity in pigs 
develops within two weeks of the booster dose.
• Re-vaccination occurs six months later if the pig is still on the farm and not yet sold.
• The	vaccine	is	thermal	labile	and	needs	to	be	stored	and	transported	at	temperatures	between	2○	and	8○C	
(thus	requiring	a	cold	chain).
• Oxfendazole is administered concurrently with the vaccine during primary and booster vaccinations, as well 
as re-vaccination to treat infected pigs.
• The mode of administering the TSOL18 vaccine is deep intramuscular injection behind ear for vaccine and 
drenching for dewormer.
• The	withdrawal	period	for	the	vaccine	is	zero	days,	but	use	of	oxfendazole	requires	a	withholding	period	of	
21 days (three weeks).
Lightowlers	(2013)	indicated	that	the	most	effective	control	of	T. solium cysticerosis was usage of chemotherapy and 
vaccination every six months. The vaccination regime was based on current knowledge at the time, which indicated 
that immunity was induced by two vaccinations given approximately one month apart. More recently, it has been 
shown	that	the	immune	response	is	maintained	even	after	longer	vaccination	intervals	and	more	flexible	intervention	
strategies are possible and by the same logic based modelling vaccination and deworming of pigs at three monthly 
intervals has the potential to prevent transmission of T. solium in slaughter weight pigs (Lightowlers et al., 2016; 
Lightowlers and Donadeu, 2017)
The trials carried out in Uganda by GALVmed aimed to evaluate concurrent treatment of porcine cysticercosis, 
with the TSOL18 vaccine and oxfendazole administered to pigs exposed to natural T. solium	infections	under	field	
conditions in Uganda. Results showed that three monthly interventions with the TSOL18 vaccine (Cysvax™) and the 
dewormer Paranthic™ eliminated cysts in pigs (Nsadha et al., 2021). The intervention regimen was safe (no adverse 
reactions), and there were high levels of compliance and acceptance. In addition, anecdotal evidence from pig 
farmers	indicated	there	were	economic	benefits.	Similar	trials	have	been	carried	out	in	Nepal,	Tanzania	and	Zambia	
and	also	demonstrated	the	same	high	level	of	efficacy	of	this	control	strategy	(Poudel	et	al.,	2019;	Gabriël	et	al.,	
2020; Kabululu et al., 2020). 
4. Characteristics of the porcine cysticercosis 
    vaccine product (TSOL18 vaccine and   
    oxfendazole)
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5. Background to the study
As part of the programme Protecting Livestock, Saving Human Life, funded in part by the UK Government 
(formerly Department for International Development, DFID, currently the Foreign, Commonwealth and Development 
Office,	FCDO)	and	the	Bill	&	Melinda	Gates	Foundation,	GALVmed	was	implementing	activities	aimed	at	controlling	
porcine	cysticercosis	in	pigs	in	Uganda.	Initial	field	tests	have	confirmed	the	efficacy	of	the	combined	use	of	
the TSOL18 vaccine and oxfendazole. In addition, farmers in the pilot study reported improved weight gain in 
vaccinated pigs compared to non-vaccinated ones (probably due to reduction of helminths), and pigs attracted 
a	higher	market	price.	Farmers	also	claimed	that	it	was	easier	to	sell	pigs.	Due	to	these	benefits,	there	could	be	
potential for marketing the porcine cysticercosis vaccine as a private good. At the same time, experience and 
a review of the literature show that poor smallholder farmers are unlikely to invest in preventive animal health 
treatments,	even	highly	effective	ones;	this	can	undermine	a	purely	market-driven	approach.	In	addition,	the	
technical	features	of	the	package	can	both	incentivise	and	de-incentivise	farmer	adoption	(e.g.,	benefits	from	
controlling other parasites versus the need for a booster).
The purpose of this porcine cysticercosis market scoping exercise was to gain a clear understanding of the 
opportunity	for	‘private	good’	marketing	of	the	TSOL18	vaccine	and	oxfendazole.	It	also	aimed	to	quantify	the	




into the market related to porcine cysticercosis in Uganda by thoroughly describing the possible market routes 
for the TSOL18 vaccine and oxfendazole, highlighting any potential marketing challenges, providing insight into 
strategies for engaging other pig value chain partners with capacity to undertake large-scale sustainable porcine 
cysticercosis	vaccination	delivery,	and	identifying	key	interventions	that	have	potential	to	benefit	producers	and	
other value chain stakeholders.
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The study’s main objective was to understand market opportunities for the TSOL18 vaccine and oxfendazole in 
order to:
i. Determine whether pig producers are willing to pay (and if so, how much) for vaccination and treatment 
against porcine cysticercosis as a routine practice;
ii. Evaluate animal health delivery and the ability to market both products; and
iii. Discuss with key stakeholders – and report recommendations on – the potential for large-scale, 
sustainable private-sector distribution mechanisms for the TSOL18 vaccine in Uganda.
6. Study objectives
26
7. Methodology for the market 
scoping studies
7.1 Study site selection
The	market	scoping	studies	took	place	in	Uganda’s	Masaka	and	Bukedea	districts	(figure	6).	Masaka	was	selected	
because it has the highest pig population density in Uganda and because the International Livestock Research 
Institute’s smallholder pig value chain projects have been active there in terms of undertaking research. ILRI have 
established strong partnerships with local government and pig value chain actors. Bukedea was selected because 
porcine cysticercosis vaccine trials are being carried out with GALVmed in the district. This was to leverage existing 
information on vaccine trials and porcine cysticercosis awareness. For the consumer studies, Kampala and 
Mukono districts were selected because they have the highest number of pork consumers in the country.
Figure 6: Map of Uganda showing the study sites
7.2 Field studies 
Several	scoping	studies	targeting	different	nodes	of	the	pig	value	chain	were	conducted.	The	focus	and	approach	
of each are summarised below:
7.2.1 Farmers’ willingness to pay for TSOL18 vaccine and oxfendazole
Objective: Assess farmers’ willingness to pay for the TSOL18 vaccine-oxfendazole product combination




Location: Masaka and Bukedea districts
Theoretical framework of choice experiment: 
A choice experiment is a multi-trait/multi-attribute stated preference method that assesses the value of single traits 
of a bundled good by using individuals’ stated preference in a hypothetical scenario.1 The traits to be valued – as 
well	as	value	levels	–	are	identified	and	combined	according	to	an	experimental	design	to	create	sets	of	discrete	
choice alternatives. Respondents are then presented with a series of choice alternatives and asked to choose 
their most preferred option. Each alternative is characterised by a number of traits, one of which is a monetary 
trait	offered	at	different	levels	across	alternatives.	Analysts	can	then	assess	how	respondents’	choices	change	as	
the traits and monetary amounts are varied. Appropriate models are then applied to the choice data to reveal a 
measure of utility for the traits of the choices.2  The choice experiment method is particularly useful for valuing traits 
without	market	values	since	the	trade-offs	that	people	make	within	traits	demonstrate	a	willingness	to	pay.3 
The theoretical framework for choice experiments derives from Lancasterian consumer theory and discrete choice 
random utility theory.4  The Lancasterian framework postulates that utility (U) is derived from traits or attributes of 
goods (zi) rather than the good per se, assuming a random utility function, depicted as:
Unjt = β0nj + γn Pnjt + βn Xnjt + εnjt
Here, Pnjt denotes the cost parameter or price of alternative j, which is often included as one of the attributes of 
the choice alternative. Xnjt denotes the other observed attributes of choice alternative j.	The	constant,	β0nj	denotes	
individual	n’s	choice-specific	intercept	for	alternative	j; γn	is	the	coefficient	for	the	cost	parameter,	and	βn represents 
the	coefficient	vectors	for	the	other	traits	for	individual	n. The implicit prices (willingness to pay) for the traits can be 
estimated as the rate of change in the trait divided by the rate of change of the cost parameter (marginal rate of 
substitution) represented as:
1  Louviere, J.J., Hensher, D.A, Swait, J.D., 2000. Stated choice methods, analysis and application. Cambridge University Press.
2  Train, K., 2003. Discrete choice methods with simulation (1st ed.). Cambridge University Press. 
3  Loomis, J., 2005. Economic values without prices: The importance of nonmarket values and valuation for informing public policy 
debate. Choices, 20(3), 179-181.




Table 1: Attributes used to study pig farmers’ willingness to pay for the porcine cysticercosis vaccine
Attribute/Trait Levels
A. Cost of vaccination (includes 
the cost of two doses of 
oxfendazole and TSOL18 
vaccine)
0.  UGX10,500 (US$2.92)
1.  UGX13,500 (US$3.75)
2.  UGX18,000 (US$5.00)
B. Administration of vaccine 
(service fee for the 
veterinarian/ animal health 
worker without including 
transport)
0.  UGX2,500 (US$0.69) per pig – service fee for veterinarian/animal health 
worker who administers vaccine and deworming service to a group of 10 
farmers
1.  UGX4,000 (US$1.11) per pig – service fee for veterinarian/animal health 
worker who administers vaccine and deworming service to one farmer
2.  UGX6,000 (US$1.67) per pig – service fee for veterinarian/animal health 
worker who administers vaccine and dewormer to one farmer
C. Improved pig weight gain 0.  Pig gains an extra 10% weight because other worms are killed 
1.  Pig gains an extra 5% weight because other worms are killed 
D. Price premium for vaccinated 
pigs
0.  50% of market price
1.  30% of market price
2.  15% of market price
E. Frequency	of	vaccination	to	
attain immunity
0.  Once at 2 months old
1.  Twice (one dose at 2 months old and another dose three months after) 
2.  Three times (one dose at 2 months of age, second dose three months 
later, and a third dose after another three months)
F. Vaccine viability detector 0.  Non-inclusion of an indicator to test for vaccine viability 
1.  Inclusion of indicator that shows vaccine viability






estimates (Rose and Bliemer, 2004) 
These	choice	sets	were	used	to	construct	cards	with	pictorial	profiles	describing	the	differences	in	traits	and	
levels to demonstrate each choice set to pig farmer survey respondents (see annex 3). The 12 choice sets were 
blocked into two groups of six choice sets each. Each pig farmer was presented with six choice sets. The choice 
experiment	was	administered	as	part	of	a	short	farm-level	survey	questionnaire	using	in-person	interviews.	The	rest	
of	the	questionnaire	covered	socioeconomic	aspects	such	as	location	of	the	farm	and	other	household-	and	farm-




the porcine cysticercosis vaccine that will soon be introduced into the market in Uganda and the importance 
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of feedback from pig farmers to the vaccine manufacturer. They were then presented with the choice cards 
developed	from	the	information	in	table	1	in	the	form	of	pictorial	profiles.	They	were	shown	three	vaccine	choice	
options at a time for each of the six choice sets and asked to choose the most preferred vaccine to purchase. In 
each case, a ‘no-buy’ option was also presented for farmers who preferred none of the three options. A total of 
294 farmers from Masaka and Bukedea districts (140 and 154, respectively) participated in the choice experiment 
interviews. Each farmer responded to six choice sets, yielding a total of 1,764 observed choices.
A conditional logit model using NLOGIT 6	(Econometric	Software	Inc.)	was	applied	to	assess	factors	influencing	
choice and to estimate the implicit prices (i.e., willingness to pay) for the traits. Table 2 presents the choice 
experiment variables used in the model and the coding of their corresponding levels.
Table 2: Choice experiment variable coding
Variables Units/coding of the variable levels
Cost of vaccine Cost in US$
Premium price Premium price in US$ (top-up premium price due to vaccination)






0=Once at 2 months
-1=Three times
Weight gain Weight gain in kilograms
Vaccine viability detector 1=Inclusion of a vaccine viability detector
-1=Non-inclusion of a viability detector
Vaccine administration cost Cost in USD
7.2.2 Traders’ willingness to pay for porcine cysticercosis-vaccinated pigs
Objective: Determine whether pig traders are willing to pay premium prices to pig farmers for T. solium-free pigs 
(i.e., vaccinated) 







vaccine that will soon be introduced into the market in Uganda and the importance of feedback from pig farmers to 
the vaccine manufacturer. The traders were then presented with the choice cards developed from the information 
in	table	3	in	the	form	of	pictorial	profiles.	They	were	shown	three	vaccine	choice	options	at	a	time	for	each	of	the	
eight choice sets and asked to choose the most preferred vaccine to purchase. In each case, a ‘no-buy’ option 
was also presented for farmers who preferred none of the three options. A total of 33 traders from Bukedea district 
participated in the choice experiment interviews. Each trader responded to eight choice sets, yielding a total of 264 
observed choices.
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Table 3: Attributes used to study traders’ willingness to pay for the porcine cysticercosis vaccine
Variables Units/coding of the variable levels
A. Top-up premium price due to 
porcine cysticercosis-vaccinated pig
1.  5% top-up
2.  10% top-up
3.  15% top-up
4.  20% top-up
B. Market price of pig (average of a 
40-kilogram pig)
1.  UGX155,000 (US$43.06)
2.  UGX200,000 (US$55.56)
3.  UGX225,000 (US$62.50)
4.  UGX250,000 (US$69.44)
C. ++Proof of vaccination 1.  Producer’s word
2.		Certificate	provided	by	a	government	veterinarian
3.		Certificate	provided	by	a	private	veterinarian
4.  Vaccinated pigs are ear-tagged
D. Improved carcass weight gain 1.  Pig gains an extra 15% carcass weight because other worms are 
killed
2.  Pig gains an extra 10% carcass weight because other worms are 
killed 
3.  Pig gains an extra 5% carcass weight because other worms are 
killed 
US$1 is equivalent to UGX 3600
7.2.3 Consumer perceptions on porcine cysticercosis-free pork
Objective: Analyse practices around the consumption of safe pork in general and consumer awareness of porcine 
cysticercosis and cystic pork at retail outlets
Participants: Four groups of consumers (2 groups of men and 2 groups of women)
Approach: Focus group discussions
Location: Two divisions in Kampala – Makindye and Nakawa divisions
Four focus group discussions with pork consumers were held in Makindye and Nakawa divisions in Kampala 
district using a checklist for guiding discussions (annex 4). The two divisions have the highest number of pork joints 
in Kampala district, a proxy for high number of pork consumers. Two focus group discussions per division (four 
total) were held, covering a total of 50 consumers (25 men and 25 women). Posters and pictures were used to 
illustrate	the	life	cycle	of	the	tapeworm.	Pictures	showing	cystic	pork	and	non-cystic	pork	of	different	qualities	were	
presented to participants to assess knowledge and preferences.
7.2.4 Consumers’ preference for safe food from animal sources
Objective: Assess consumers’ preference for safe food from animal sources 
Participants: 47 (24 women and 23 men)
Approach: A simulated egg experiment with consumers (due to ease of handling eggs compared to other animal-
source foods such as pork)
Location: Goma and Kyaggwe sub-counties in Mukono municipality 
Four	different	egg	types	and	qualities	were	purchased	and	used	for	the	experiment.	Equal	amounts	of	each	type	
were	presented	to	the	consumers	during	the	experiment.	The	per-unit	prices	of	the	different	egg	types	varied,	with	
costs based on actual market prices:
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• Regular eggs (eggs from local hens kept under backyard systems): UGX600 (US$0.17)/egg
• Antimicrobial-free eggs – organic eggs: UGX700 (US$0.19)/egg
• Eggs from hens vaccinated against Newcastle disease: UGX400 (US$0.11)/egg
• Eggs from hens that have been vaccinated against Newcastle disease and are antimicrobial-free – 
UGX1,200 (US$0.33)/egg 
At the start of each experiment, per site, a workshop-like format was adopted to provide participants with 
detailed	information	on	the	effects	of	antimicrobial	residues	and	Newcastle	disease	on	human	health.	Posters	
and	pictures	were	used	for	illustration,	and	the	different	eggs	in	the	market	were	explained	in	detail.	After	this,	
each of the participants was given UGX5,000 (US$1.39) to individually purchase at least four eggs from any 
of the egg categories in the market. They were allowed to keep leftover money from the purchase. This was 
to avoid the known hypothetical bias that occurs with stated preference methods such as choice experiments 
when participants make purchases with imaginary or endowed money and to create a real world situation where 
participants	would	buy	as	frugally	or	extravagantly	as	they	would	with	their	own	money.	A	short	questionnaire	was	
then administered to each participant to collect information on the number and type of eggs purchased, as well as 
other socio-demographic characteristics.
7.2.5	 Therapeutic	product	profiling
Objective: Determine potential market entry points and barriers for the TSOL18 vaccine-oxfendazole package 
Participants: 21 drug stockists
Approach: Individual interviews and observations
Location: Masaka and Bukedea districts
In	both	districts,	a	list	of	all	drug	stockists	registered	at	the	District	Drug	Inspector’s	Office	was	generated.	In	
Masaka, 11 of 16 drug stockists (79%) were interviewed, while in Bukedea all 10 drug stockists were interviewed 
(100%). In Masaka, interviews took place between 20 and 27 October 2017, while in Bukedea they took place 
between 31 October and 4 November 2017. An interview was conducted with each stockist, which took about 
two to three hours each and involved visual inspection of products. Data were entered into Microsoft Excel and 
Stata for analysis.
7.2.6 Service providers’ willingness to sell the TSOL18 vaccine and oxfendazole
Objective: Assess the perspective of the veterinarians and para-veterinarians on their willingness to sell the 
TSOL18-oxfendazole package and farmers’ willingness to buy it
Participants: 22 veterinarians
Approach: Focus group discussion Location: Masaka and Bukedea districts
The heads of both districts’ veterinary departments were asked to invite all the veterinarians and para-veterinarians 
that operate in the municipality (for Masaka) and town council (for Bukedea). Twelve veterinarians in Masaka 
and 10 veterinarians in Bukedea were interviewed. The focus group discussion for Masaka took place in Katwe 
Butego sub-county on 20 October 2017, while in Bukedea it took place in Bukedea Town Council on 31 October 
2017. Each session lasted about two hours, and a checklist was used to guide the process. For the focus group 
discussion, there was a session facilitator and a note-taker that recoded all of the responses to the checklist.
7.2.7 Potential for large drug distributors to market TSOL18 and oxfendazole
Objective: Assess the distribution channel for pig dewormers and livestock vaccines and large stockists’ 
willingness to distribute the product (TSOL18-oxfendazole package)
Participants: Two veterinary drug distributors 
Approach: Face to-face interviews
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Location: Kampala
Two major veterinary drug distributors participated in the study. The research team conducted a two-hour face-
to-face	interview	with	the	executives	of	these	companies	at	their	head	offices	in	Kampala.	The	discussions	were	
centred around brands of dewormers distributed (with emphasis on oxfendazole), channels of distribution, and the 
regulatory framework for drugs and vaccine distribution.
7.2.8 Stakeholder meeting in Uganda
Objective: Discuss with key stakeholders – and report recommendations on – the potential for large-scale, 
sustainable private sector distribution mechanisms for the TSOL18 vaccine in Uganda





one drug stockist, one experienced veterinarian, one individual from the National Drug Authority veterinary section, 
one drug stockist, and one focal person for ‘One Health’ at the Ministry of Agriculture, Animal Industries, and 
Fisheries. Invitation letters were sent out, and four of the six attended the meeting on 4 December 2017 at the ILRI 
offices	on	Naguru	Katalima	Road	in	Kampala.	The	meeting	started	at	10	a.m.	and	ended	at	midday.	A	checklist	
was administered to participants in the form of a discussion and their responses were noted. 
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8. Results
8.1  Farmers’ willingness to pay for TSOL18 and oxfendazole
8.1.1 Surveyed farmers’ socio-demographic characteristics
Of the interviewed farmers, 63% were female and 37% were male. The average age of the farmers was 39.2 
(±13.7).	About	half	of	the	farmers	interviewed	reported	having	primary-level	education	(figure	7),	and	48%	of	
households had a monthly income of less than UGX100,000 (US$28) per month (table 4). The farmers had an 
average total herd size of 3.8 pigs (±4.4), with at least one sow and one weaner. Various categories of pigs were 
sold	by	farmers	in	the	previous	six	months	(table	5).	The	buyers	for	the	finishers,	sows,	and	boars	are	mainly	
butchers (78%), while weaners are mainly bought by individual households.
Summary of findings
• Farmers prefer vaccines that would reward them in terms of yielding a high premium price for vaccinated 
pigs, as well as vaccines administered only once at 2 months old to attain immunity. 
• Key attributes highly valued by farmers included a high premium price due to porcine cysticercosis vaccina-
tion and the inclusion of a vaccine viability detector. Farmers indicated willingness to pay US$0.44 more if 
the vaccine results in an additional dollar premium price, as well as US$4 if the vaccine comes with a viability 
detector. 
• The farmers had a high preference for a vaccine that is only administered once to achieve porcine cysticer-
cosis immunity and indicated willingness to pay US$1.67 more compared to one that is administered three 
(is this missing from table 6 and 7) times. 
• The farmers preferred a vaccine associated with low administrative costs.



























Table 4: Respondents’ household income category
Income category (in UGX) % of households





More than 500,000 7.8
Table 5: Respondents’ number of pigs sold in the previous six months
Pig category Average numbers sold 
(standard deviation in 
parenthesis)
Min. Max.
Boars 0.6 (1.3) 0 14
Sows 0.6 (1.3) 0 13
Gilts 0.3 (1.2) 0 12
Weaners 1.1 (4.5) 0 50
Finishers 0.5 (1.2) 0 9
Piglets 0.9 (2.8) 0 25
8.1.2 Awareness of porcine cysticercosis
Fifty-five	per	cent	of	the	farmers	interviewed	had	heard	of	porcine	cysticercosis,	and	87%	of	farmers	who	reported	




Figure 8: Respondents’ reported main source of information on porcine cysticercosis
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Figure 9: Farmers’ main reported effect of porcine cysticercosis
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Figure 9: Farmers’ main reported effect of porcine cysticercosis
Figure 8: Respondents’ reported main source of information on porcine cysticercosis
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8.1.3 Willingness to pay for porcine cysticercosis vaccine
The maximum likelihood estimates of the conditional logit model are presented in table 6. The results show that 
farmers prefer vaccines that would reward them in terms of a high premium price for vaccinated pigs and one 
that is administered only once at 2 months to attain pig immunity. The results also show a strong preference for 
a	vaccine	with	a	vaccine	viability	detector.	The	negative	and	strongly	significant	coefficient	on	cost	of	vaccine	and	
vaccine administration cost shows low preference for high vaccine and administrative costs.
Table 6: Conditional logit maximum likelihood estimates from choice experiment for porcine cysticercosis 
vaccine
Variable Coefficient Standard error Z
Constant 0.3621* 0.1966 1.84
Cost of vaccine administration -0.2514*** 0.0674 -3.23
Premium price (top-up) 0.0295*** 0.0033 9.04
Low	vaccination	frequency	(once	at	2	months) 0.1109*** 0.0363 3.06
Medium	vaccination	frequency	(twice) -0.0648* 0.0381 -1.70
Weight gain -0.0081 0.0284 -0.29
Vaccine viability detector 0.2671*** 0.0296 9.03




Estimates of the implicit prices of the traits are presented in table 7. The results show two key attributes are highly 
valued by farmers: a high premium price due to porcine cysticercosis vaccination and inclusion of a vaccine 
viability detector. Farmers are reportedly willing to pay US$0.44 more if the vaccine will result in an additional dollar 
premium price. They are also willing to pay US$4 if the vaccine comes with a viability detector. This indicates a 
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“lemons market” for veterinary drugs in Uganda: a lemons market occurs when consumers who cannot observe 
the	quality	of	a	specific	item	but	believe	that	a	fraction	of	products	in	the	market	are	low	quality	(or	counterfeit)	will	
have lower willingness to pay for the product, thereby depressing prices. A similar issue has been well described 
for pesticides in Uganda. A World Bank study found that one third of pesticides were sub-standard and that 
farmers believed 40% of pesticides were sub-standard and this substantially reduced their WTP for pesticides 
(Ashour et al., 2017)
The farmers have a high preference for a vaccine that is only administered once to achieve porcine cysticercosis 
immunity, being willing to pay US$1.67 more. Additionally, they prefer a vaccine that is associated with low 
administration	costs,	which	has	implications	for	communal	vaccination	initiatives	and	other	efforts	aimed	to	reduce	
transaction costs.
Table 7: Trait implicit prices (willingness to pay values) in US$ and UGX
Trait US$ UGX Standard 
error
Z
Vaccine administration cost 3.7754* 13,591.4 1.9869 -1.90
Price premium 0.4431** 1,595.2 0.2085 2.12
Low	vaccination	frequency	(once	at	2	months) 1.6651* 5,994.4 0.9287 1.79
Medium	vaccination	frequency	(twice) 0.9723 3,500.3 0.7198 -1.35
Weight gain 0.1217 438.1 0.4323 0.28
Vaccine viability detector 4.0111** 14,439.9 1.8571 2.16
Wald Statistic=4.78289
Prob.	from	Chi-squared	[6]=0.5576
Functions are computed at means of variables.
***,	**,	and	*	denote	significant	variables	at	1%,	5%,	and	10%,	respectively
The farmers’ willingness to pay (WTP) for combined features of the PC vaccine traits has been estimated using 
the compensating surplus model. The compensating surplus shows the change in income that would make a 
respondent	indifferent	between	the	base-case	(current	attributes	of	the	PC	vaccine)	and	subsequent	alternative	
scenarios	with	specified	combination	of	the	vaccine	traits.	The	compensating	surplus	(CS)	model,	is	calculated	as:
Where	βcost	is	the	coefficient	associated	with	the	cost	of	the	vaccine,	V0 is the expected utility from the base case 
attributes of the vaccine, and Vn is the utility of an alternative vaccine scenario. Table 8 presents the farmers WTP 
for two PC vaccine scenarios containing an improved combination of the vaccine attributes. The WTP estimate 
of the base scenario of the vaccine (current existing attributes), until the pig attains immunity is US$2.61, though 
only 19% of the surveyed farmers selected that vaccine combination. The improved traits of the vaccine results in 
higher farmer WTP. For instance, scenario 1 of the attributes (lower administration cost and a 50% price premium) 
was selected by 37% of the farmers and result in a WTP of US$12.84. The WTP for scenario 2 (50% price 
premium, vaccine viability detector and a 10% increase in pig live-weight) is US$16.94 selected by 49% of the 
farmers. The results show that under baseline scenario – which mimics current vaccine attributes, only few farmers 
would be WTP for the vaccine. Farmers are interested to pay for the vaccine if they are assured of a price premium 
and	have	confidence	in	the	quality	of	the	vaccine	(through	a	viability	detector).
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Table 8: Estimates of respondents’ willingness to pay (WTP) for combined attributes associated with TSOL18 - 
oxfendazole porcine cysticercosis vaccine (three scenarios)
Attribute WTP in Uganda 
Shillings (UGX)
WTP in US Dollars 
(US$)
% of farmers choosing 
the vaccine option 
(n=294 farmers)
Base scenario
ADMIN COST PER PIG – UGX6000
PRICE PREMIUM – 15% of market price
VACCINATION FREQUENCY – twice
WEIGHT GAIN – 5%
VIABILITY DETECTOR - none
9,396 2.61 19.73
Scenario 1
ADMIN COST PER PIG – UGX2500
PRICE PREMIUM – 50% of market price
VACCINATION FREQUENCY – once
WEIGHT GAIN – 5%
VIABILITY DETECTOR - none
46,224 12.84 37.41
Scenario 2
ADMIN COST PER PIG – UGX6000
PRICE PREMIUM – 50% of market price
VACCINATION FREQUENCY –once
WEIGHT GAIN – 10%
VIABILITY DETECTOR - yes
60,984 16.94 48.98
8.2 Traders’ willingness to pay for porcine cysticercosis-vaccinated pigs
8.2.1 Socio-demographic characteristics of the traders and porcine cysticercosis awareness
The average age of the traders interviewed was 36, and 85% reported having primary-level education. The traders 
sold an average of six to 10 pigs per month between May and October 2017. Most of the interviewed traders 
(94%) said they had heard of porcine cysticercosis. Their main source of information on porcine cysticercosis was 
fellow	traders	and	veterinary	officers	and	animal	health	assistants	(figure	10).
Summary of findings
Traders are aware of porcine cysticercosis; 94% of traders interviewed had heard of it.
Most	of	the	traders	(94%)	said	they	reject	(i.e.,	do	not	purchase)	pigs	suffering	from	porcine	cysticercosis.	In	
some	cases,	they	offer	lower	prices	for	these	pigs.
The traders are concerned about consumers’ health, and 96% condemned infected pigs/pork.
Pigs’ weight gain was traders’ most preferred attribute.
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Table 9: How traders recognised porcine cysticercosis
Identification method Traders 
Performed lingual palpation (below tongue) 15 (40%)
Poor	quality	pork	from	slaughtered	pigs 10 (27%)
Worms below the ears 1 (3%)
Hair	on	back	of	animals	falling	off 1 (3%)
8.2.2 Traders’ perceptions and preferences related to porcine cysticercosis
The traders reported being concerned about consumers’ health, with 96% condemning infected pigs/pork (table 
10).	They	reported	believing	that	the	vaccine	and	dewormer	are	the	most	effective	means	of	controlling	the	
disease. Eighty-one per cent, however, believe that controlling porcine cysticercosis is the government’s role and it 
should therefore subsidise the cost of the vaccine.
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Table 10: Traders’ perceptions about porcine cysticerocisis and the TSOL18 vaccine/oxfendazole combination
Statement Level of agreement
Strongly 
disagree
Disagree Neutral Agree Strongly 
agree
A. I believe it is important to protect my consumers’ 
health by ensuring that I sell porcine cysticercosis-free 
pigs/pork.




B. I condemn pork/pigs infected with porcine 
cysticercosis.




C. The market system should encourage farmers to 
vaccinate their pigs against porcine cysticercosis by 
giving premium prices.




D. From the information and discussions we had today, I 
believe the porcine cysticercosis vaccine + deworm-
er	is	the	most	effective	option	for	controlling	porcine	
cysticercosis.




E. I feel that control of porcine cysticercosis is the role of 
the government and it should therefore subsidise the 
cost of the vaccine.




F. Public health is the role of the government, not the 
pig traders.




G. I don’t care about porcine cysticercosis-infected pigs 






0 (0%) 0 (0%) 0 (0%)
Table 11 presents the maximum likelihood estimates of the conditional logit model. The constant parameter 
representing	the	‘no-buy’	option	is	positive	and	statistically	significant	at	10%.	The	‘no	buy’	choice	alternative	is	the	
base for the choice model and is associated with ‘zero utility’. Traders selected at least 4.9% of the ‘no-buy’ choice 
options.	The	coefficient	on	weight	gain	was	positive	and	significant	at	5%,	indicating	preference	for	the	increased	
pig	live-weight	gain	attribute.	Most	of	the	variables	are	not	statistically	significant	and	should	be	interpreted	with	
caution due to the low sample size.
Table 11: Conditional logit maximum likelihood estimates from choice experiment for the porcine cysticercosis 
vaccine
Variable Coefficient Standard error Z
Constant 0.9727* 0.5265 1.8475
Pig purchase price in US$ 0.0062 0.0075 0.8332
Top-up price premium in US$ 0.0190 0.0214 0.8909
Weight gain 0.0948** 0.0392 2.4186
Private	sector	vaccine	certification 0.0214 0.1162 0.1844
Pig tagging as vaccination proof 0.0609 0.1154 0.5276





8.3 Consumer perceptions on porcine cysticercosis-free pork
8.3.1 Demographic characteristics of respondents
Across the two divisions in Kampala where the study took place, the participants were from diverse ethnic groups 
with	different	cultural	values,	norms,	and	experiences	relating	to	pork	consumption.
8.3.2 Safe pork consumption
Consumers across the two divisions reported that the most important factors to consider for ensuring that 
consumed	pork	is	safe	relate	to	environmental	factors	associated	with	the	pork	joint,	as	well	as	pork-quality	
attributes. These included the hygiene of the pork joint, the person handling the pork, the plates, and the kitchen 
where pork is prepared. Hygiene was considered by the participants to be the most important attribute because 
poor hygiene could lead to illnesses like diarrhoea, cholera, and tapeworm. Participants in the focus group 
discussions noted (parentheses indicate discussion location and date):
“My life is my priority, thus I have to eat from a clean environment in order not to contract diseases”  
 (Nakawa, 7 November 2017). 
“Hygiene is important because I can avoid health-related problems associated with contaminated  
 pork” (Makindye, 5 November 2017).
“Cleanliness of the place is vital because eating from a dirty environment can be very expensive   
 because after eating, you have to go for treatment. Hence, it is better to eat from a place which cannot  




method. Participants in the focus group discussions noted (parentheses indicate discussion location and date):
“Well-cooked pork doesn’t contain diseases because all the liquid is dried out” (Nakawa, 6 November 
2017).
“Pork takes a very short period to go bad. That is why I want the fresh pork, which is free from 
contamination” (Nakawa, 7 November 2017).
“I like lean pork because the fats may cause illnesses in my body that I don’t know” (Makindye, 5 
November 2017).
8.3.3 Gendered knowledge related to T. solium cysticercosis
Generally, both male and female focus group discussion participants had some knowledge of T. solium 
cysticercosis and were able to describe the signs of infection and how it is transmitted; two men and one woman 
(of 48 total participants) had never heard of it. Although almost all respondents knew about tapeworms in humans, 
none knew about cysts in pork. Additionally, some of the information participants provided about tapeworms was 
inaccurate. Focus group discussion participants noted (parentheses indicate discussion location and date):
“Tapeworm is got through eating leftovers/food that have stayed overnight, and sign I know is swollen  
 stomach, especially in children” (Nakawa, 6 November 2017).
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“When one eats raw/half-cooked food like potatoes, cabbages, and cassava, one can get tapeworms,  
 and one of the signs is severe headache, diarrhoea and loss of appetite” (Makindye, 5 November  
 2017).
“One can get tapeworm through eating meat from animals which have not been dewormed. This can  
 cause body weight loss, vomiting, and anaemia” (Makindye, 10 November 2017).
“Tapeworm is transmitted through eating raw food which the enzymes cannot digest. The signs
include very high appetite, itchy behind, constipation, and crumps (stomach makes noise like   
 ‘kukukuku…’)” (Nakawa, 7 November 2017).
Most of the women (in contrast to the men) reported that had actually seen tapeworms, especially in children’s 
faeces, and two women actually noted that they were once victims of tapeworm.
Summary of findings
• Consumer focus group discussion participants considered hygiene to be the most important factor in ensur-
ing pork is safe because poor hygiene could lead to illness like diarrhoea, cholera, and tapeworm.
• Participants noted pork’s leanness and fat content, freshness demonstrated through colour, and cooking 
method	as	pork	quality	attributes	they	look	for.	
• Although almost all participants had knowledge on tapeworms in humans, none knew about cysts in pork. 
Some information they provided on tapeworms was inaccurate.
• The	most	significant	source	of	information	on	tapeworms	amongst	participants	was	the	home/parents	and	
particularly mothers.
• Female participants reported being more observant in terms of taking relevant safety measures in terms of 
food.
• Although participants were trained about the dangers of eating pork with cysts, most said they cannot throw 
away what they have already bought and would rather cook the pork thoroughly to kill the cysts. Both male 
and	female	participants	in	both	divisions	noted	willingness	to	pay	more	for	pork	certified	to	be	porcine	cystic-
ercosis-free as long as their safety is guaranteed.
8.3.4 Participants’ information sources on tapeworm
Participants	noted	a	variety	of	channels	as	their	information	sources	on	tapeworm,	with	the	most	significant	source	
given being the home/parents and particularly mothers; other sources included schools, hospitals, seminars, and 
village	health	teams.	There	was	no	significant	difference	between	male	and	female	respondents.	Focus	group	
discussion participants noted (parentheses indicate discussion location and date):
“My mother was a traditional herbalist, so I learnt from her because she used to treat children in our  
 village who had tapeworm” (Nakawa, 6 November 2017).
“My siblings suffered from tapeworms, and when my mother took them to the hospital, the nurses
told her it was tapeworms. Then she came back, she informed us about tapeworms and its effects”  
 (Nakawa, 7 November 2017).
8.3.5 Pork cysts
The consumer focus group participants were asked if they had ever seen cystic pork. Six of the 25 men (24%) 
had seen pork with cysts either in Kampala or in their home districts; ten of the 25 women (40%) had seen cysts 
in	various	pork	retail	outlets.	Participants	attributed	the	gender	difference	to	men	being	less	vigilant:	Most	men	
order pork by calling the pork joint owners, and by the time they get to the joint, the pork is ready for consumption; 
female consumers, on the other hand, buy fresh pork to prepare at home and are therefore able to inspect pork 
42
before purchase. Despite the fact that both male and female consumers have observed cysts in the pork, their 
assumption was that the pork was just fatty. Focus group discussions participants noted (parentheses indicate 
discussion location and date):
 “I saw pork with cysts in my village, but we had to bury it. It is a tradition in my family that our father  
 slaughters for us a pig every 23rd December, but last year the pig which was slaughtered had cysts  
 and my father had to bury it and slaughtered another one” (Makindye, 5 November 2017).
“I saw pork with cysts here in Kampala at one joint” (Nakawa, 7 November 2017).
After the sensitisation sessions on pork tapeworm, all focus group discussion participants indicated that when 
cystic pork is bought on their behalf, the pork would be returned to the seller. Participants generally indicated they 
would	not	buy	cystic	pork	at	the	butcher,	although	some	said	they	might	purchase	the	cystic	pork	and	request	the	
pork handler ensure it is well prepared (dried). Although consumers were trained about the dangers of eating pork 
with cysts, most consumers noted that they cannot throw away what they have already bought but would rather 
cook the pork thoroughly in order to kill the cysts. Focus group discussion participants noted (parentheses indicate 
discussion location and date):
“We roast the pork very well until when it is fully roasted and just cook it in groundnuts, and we eat”  
 (Makindye, 5 November 2017).
“In case we have sent someone else to pick for us, we take back the pork to the butcher, educate  
 him about the dangers of consuming pork with cysts and also teach the consumers whom we will  
 find in the butcher and urge them not to buy such pork again because it is not healthy” (Nakawa, 6  
 November 2017).
“When we see such pork, we advise the butcher person the effects of the tapeworm, and we also  
 advise him not to sell, and if he refuses, we call the public veterinarian (Nakawa, 7 November 2017).
“When we see it on the butchery, we just call the concerned health people like the veterinary officer or  
 Local Council administrators (LCs) at any level, and the owner should tell the community where he got  
 the sick pork which was not inspected” (Nakawa, 6 November 2017).
8.3.6	 Willingness	to	pay	premium	prices	for	pork	certified	as	porcine	cysticercosis-free
Men	and	women	in	both	divisions	indicated	they	were	willing	to	pay	more	for	pork	certified	as	porcine	
cysticercosis-free as long as their safety is guaranteed. However, they noted that they have no control for food 
safety	regulations	and	that	in	case	food	standard	regulations	are	put	in	place,	they	would	rather	reduce	the	quantity	
of	pork	consumed	and	focus	on	quality.	They	noted	(parentheses	indicate	discussion	location	and	date):
“Life is important, and when lost, one can’t regain it. Thus, safety first” (Nakawa, 7 November 2017).
 “Because we are concerned about our health, we would rather pay for expensive pork which is safe  
 for our lives than eating the unsafe pork” (Makindye, 5 November 2017).
“I will buy and continue to eat pork irrespective of the price as long as the pork is safe for   
 consumption” (Nakawa, 6 November 2017).
Although most consumers indicated their willingness to pay premium prices for pork certified as   
 porcine cysticercosis-free, one consumer said if price increased, he would stop eating pork because it  





Choice A: UGX13,000 (US$3.61)/kg (somewhat lean pork)
Choice B: UGX6,000(US$1.67)/kg (leftover parts of pork and pig
parts sold after slaughter)
Choice D: UGX10,000 (US$2.70)/kg (fatty pork)
Choice C: UGX15,000 (US$4.17)/kg (lean pork)
Each participant was asked to select their preferred type. Figure 11 shows that 58% of the consumers preferred 
choice C, the leanest and most expensive at UGX15,000 (US$4.17) per kilogram, followed by 32% preferring 
choice	A,	which	was	the	second-best	quality	and	priced	at	UGX13,000	(US$3.61)per	kilogram.	Choice	B	–	leftover	
parts of pork and pig parts sold after slaughter priced at UGX6,000 (US$1.67) per kilogram – was selected by 8% 
of participants, and 2% selected Choice D, fatty pork priced at UGX10,000 per kilogram.
The	findings	show	that	consumers’	preference	is	tagged	to	quality	of	pork,	although	this	may	not	necessarily	
translate to actual purchases due to budget constraints. They were also probably using price as a proxy for pork 
quality.


























division mostly preferred choice set C (32% and 28%, respectively) compared to Makindye (16% and 14%, 
respectively).



























diseases or infections; this was similar in all the focus group discussions and across gender and division. However, 
14% of women in Makindye chose choice A because they considered the price of pork as favourable compared 
with 2% of the women in Nakawa; choice A was a mixture of bones and meat, and the participants indicated that 
‘the nearer the bone, the sweeter the money’.
8.4 Consumers’ preference for safe food from animal sources
8.4.1 Socio-demographics
Participants’ mean age was 51 (table 12). Most of the respondents (43%) had attained secondary school-level 
education	(‘O’	level),	while	17%	and	19%	had	university-	and	tertiary-level	training,	respectively	(figure	13).	Forty-
two per cent of the consumers reported a total monthly household income above UGX400,000 (US$111), while 
30%	have	an	income	of	less	than	UGX200,000	(US$55.50)	(figure	14).
Summary of findings
• Although consumers may be aware of safe foods, their preferences as depicted by actual purchases are 
driven	by	other	factors	(such	as	personal	preferences	versus	food	safety),	and	they	may	have	a	different	
perception of what is considered ‘safe food’. 
• Most of the consumer participants (85%) strongly agreed that it is important to protect their family’s health by 
ensuring they purchase safe food from animal sources.
Table 12: Mean age of the respondents
Observations Mean Standard deviation Minimum Maximum
 Age 47 50.6 14.4 23 83
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Figure 13: Highest attained education level reported by respondents
Table 11: Mean age of the respondents













Primary O’Level A’Level University Tertiary Vocational
%




less than 200,000 UGX
200,001 UGX-400,000 UGX
400,001 UGX and above
8.4.2 Results of simulated egg market
Regular eggs were the most preferred and purchased eggs by the consumers, with participants purchasing an 
average of three regular eggs (table 13). The preference for regular eggs was attributed to the yellow yolk and 
belief that it is more nutritious relative to other egg types. Each consumer purchased on average one each of the 
other egg types. Fifty-four per cent of the eggs purchased were regular eggs (table 14). The ‘safest’ egg (free from 
antimicrobial residue and Newcastle disease) amounted to 24% of the purchased eggs. The pattern was not any 
different	to	any	degree	of	statistical	significance	across	gender	(table	15).
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Table 13: Type of eggs purchased by respondents
Egg type Number Mean Standard 
deviation
Minimum Maximum
Regular eggs 47 3.0 2.6 0 8
Antimicrobial residue-free eggs 47 0.6 0.9 0 4
Eggs from Newcastle disease-vaccinated 
hens
47 0.5 1.3 0 5
Eggs free from antimicrobial residue and 
Newcastle disease
47 1.2 1.6 0 4
Table 14: Total numbers of eggs purchased by respondents
Egg type Total number purchased 
Regular eggs 128 (54.2%)
Antimicrobial residue-free eggs 29 (12.3%)
Eggs from Newcastle disease-vaccinated hens 23 (9.7%)
Eggs free from antimicrobial residue and Newcastle disease 56 (23.7%)
Total 236
Table 15: Type of eggs respondents purchased by gender 
Egg type Men Women
Regular eggs 60 (50.4%) 68 (58.1%)
Antimicrobial residue-free eggs 11 (9.2%) 18 (15.4%)
Eggs from Newcastle disease-vaccinated hens 16 (13.4%) 7 (6.0%)
Eggs free from antimicrobial residue and Newcastle disease 32 (26.9%) 24 (20.5%)
Total 119 (100.0%) 117 (100.0%)
The results show that although consumers may be aware of safe foods, their preferences as demonstrated by 
actual purchases is driven by other factors (such as personal preferences) rather than food safety. Consumers’ 
regular purchasing habits could also play a role – they may be used to purchasing regular eggs and may have 
never experienced any food safety challenges. The percentage of purchased eggs free from antimicrobial residue 
and Newcastle disease is relatively high compared to only antimicrobial residue-free or only Newcastle disease-
free, showing interest in purchasing safe products even when the price is high. Additionally, most of the consumers 
also	expressed	concern	about	lack	of	labelling	and	adequate	information	regarding	food	safety	in	market	outlets	to	
guide purchases.
8.4.3 Perceptions about safe products from animal sources
Most of the consumers (85%) strongly agreed that it is important to protect their family’s health by ensuring they 
purchase safe foods from animal sources (table 16). About half (49%) of the consumers were concerned about 
unsafe	foods	from	animal	sources	in	the	markets,	and	an	equal	number	felt	safe	foods	from	animal	sources	do	
exist in the market but are too expensive for them. Thirty-two per cent strongly disagreed that even if animal source 
foods are well cooked there is no risk associated with their consumption; this could be attributed to the fact that 
consumers learned prior to egg selection that some antimicrobial residues cannot be destroyed even with cooking.
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Table 16: Consumers’ perceptions about safe animal-source products
Level of agreement Strongly 
disagree
Disagree Neutral Agree Strongly 
agree
I believe it is important to protect my family’s 
health by ensuring that I buy safe animal-
source foods.
0 0 0 7 (15%) 40 (85%)
I am concerned about unsafe animal-source 
foods supply in our market.
1 (2%) 4 (9%) 1 (2%) 18 (38%) 23 (49%)
I feel that safe animal-source foods are 
normally too expensive.
3 (6%) 8 (17%) 2 (4%) 11 (23%) 23 (49%)
I believe that if the animal-source foods are 
well cooked, there is no risk associated with its 
consumption.
15 (32%) 7 (15%) 4 (9) 12 (25%) 9 (19%)
8.5 Therapeutic products profiling
8.5.1 Dewormers sold to pig farmers
In this study, the participant drug stockists listed 21 brands of dewormers sold to pig farmers and pig health 
service providers (table 17). None of the drugs mentioned as currently sold contain oxfendazole. Only albendazole 
was mentioned as a drug that could treat tapeworms. However, when the interviewer visually inspected drug shop 
shelves	in	Masaka,	Erafen	5	(with	fenbendazole	as	its	active	ingredient)	was	found.	Praziquantal	is	available	in	
Uganda, but was not found in this survey; it has been used to treat pig tapeworm in combination with albendazole.
Summary of findings
• There appears to be substantial demand for livestock dewormers in Uganda.  
• The market for dewormers is relatively crowded; there are 21 brands of dewormers. Active ingredients 
include ivermectin, levamisole, piperazine, albendazole and fenbendazole. 
• Animal health service providers preferred ivermectin, while farmers preferred levamisole and albendazole. 
• Most other drugs are cheaper per dose than Paranthic 10% (active ingredient oxfendazole), which is an 
important consideration for farmers. 
• Albendazole and Erafen 5 (active ingredient fenbendazole) were mentioned as potential competitors for 
oxfendazole.	However,	fenbendazole	has	side	effects	and	treatment	requires	multiple	doses,	which	may	limit	
its widespread use. 
• Participants ranked farmers as the most important market segment for dewormers, followed by animal health 
service providers. Most farmers (68 to 80%) deworm their pigs an average two times per year. 
• The	market	appears	to	be	quite	price-sensitive,	with	the	most	sales	for	the	cheapest	drugs. 
• The promotion mechanisms that are most used by the distributors are door-to-door marketing and 
advertising through radio, newspapers, and television. 
• For the TSOL18 vaccine-oxfendazole combination to be competitive (viewed simply as a dewormer), it 
should be priced between US$1.62 and US$6.11.
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Table 17: Active drug ingredients and number of brands given by drug stockists





Competitors to oxfendazole fall into two categories: drugs that can be used to treat pig tapeworm and drugs that 




doses (Mkupasi et al., 2013). According to the stockists, there is currently no demand for a product that treats 
pig tapeworms; instead, farmers and animal health workers want products that treat pig parasites. This is partly 
because there are currently no well-suited products for this, but also because there is no general awareness of the 
problem. 
Additionally, when examining drug competition, it is important to look at all drugs that treat pig parasites. Table 18 
provides information on competing brands that also treat tapeworm, including Paranthic 10% (active ingredient 
oxfendazole). Table 19 discusses competing brands that treat parasites in pigs. The tables help provide information 
and context relevant to marketing oxfendazole:




• Erafen 5 packaging has a picture of a pig. However, a picture could easily be added to Paranthic 10% 
or	a	brochure	provided	with	a	picture	of	a	pig;	a	picture	is	not	a	unique	selling	point.
• Many drugs don’t list the dosage for pigs on the label. This is a limitation for the animal health specialist 
market segment. However, it is very easy for this information to be added (if the drug is licenced for use 
in pigs), so this is not the basis for a permanent market issue. 
• The oxfendazole market could be an important criterion in the future, as farmers in East Africa have a 
strong preference for ‘tried-and-true’ brands.
• Means of administration is also an important factor. Paranthic 10% is a drench, as are levamisole and 
albendazole. Ivermectin is injectable. Farmers may prefer drenches because they are unfamiliar with 
injections. For animal health workers, injections are often easier.
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Table 18: Competing brands that also treat tapeworm (assuming demand exists)



































































BW for seven 
days)*
Not indicated 0.3 0.077/dose
Paranthic 
10%***
Oxfendazole None Cattle, 
swine
30 mg/kg BW 
single dose





*Obtained from literature (Gonzalez et al., 1995)
**For comparison purposes 
***Competing product
Table 19: Competing brands that treat parasites in pigs



























































Pricing deserves special attention because poor farmers are highly cost sensitive. Cost per deworming for a 
10-kilogram pig is higher for Paranthic 10% compared with Erafen 5 – and, unlike the other drugs, this does not 
include	mark-up.	Table	20	provides	details	on	mark-ups	for	the	different	drugs	as	reported	by	the	drug	stockists.	
Albendazoles might seem more expensive, but they are not indicated for treatment of porcine cysticercosis. For 
competitor drugs, a 35% mark-up was added on top of the drug’s price when sold to stockists by the distributors. 
Piperazines had the lowest mark-up, while levamisoles had the least mark-up added. Most of the drug distributors 
give price sheets to the drug stockists. For Paranthic 10%, a mark-up of 28% would be feasible since it’s a drench 
as	an	albendazole.	The	high	standard	deviations	reported	are	due	to	large	differences	between	purchase	and	sale	
price for some of the products. For example, 100 tablet Wormcid packet (levamizole) had a distribution price of 
UGX9250 but could be sold to as high as UGX25000 to the farmers.










Ivermectin 36.1 136.7 32.1 48.4 34.8 115.0
Levamisoles 54.8 137.2 15.9 64.2 39.3 115.0
Piperazines 19.6 8.1 37.5 0.0 22.2 10.1
Albendazoles 28.0 29.8 33.4 10.9 30.5 22.4
8.5.2 Customers for dewormers (market segments)
The two major customers for dewormers are farmers and animal health service providers, which includes 
veterinarians and para-veterinarians. Some stockists also sell drugs to other stockists and organisations. Most 
customers	are	farmers	(56%	in	Masaka	and	83%	in	Bukedea)	(figure	15);	however,	other	actors	may	buy	in	larger	
quantities.	There	are	more	animal	health	service	providers	that	are	operating	in	Masaka	than	Bukedea,	and	these	
professionals are better informed and can be critical to a new product’s successful market penetration. The drug 
stockists were asked to rank customers by order of importance, and farmers were ranked as the most important 
customers	followed	by	animal	health	service	providers	(figure	16).	This	was	because	farmers	comprise	the	largest	
number of their customers and pay higher prices than animal health service providers, who are better informed 
and tend to bargain. Organisations such as the National Agricultural Advisory Services and some local non-
governmental organisations were ranked third because they are seasonal customers.
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Figure 16: Rankings of customer importance by the drug stockists











































Other studies suggest that albendazole is the most popular treatment (used by 90% of farmers), followed by 
levamisole	and	ivermectin	(Doble,	2007).	However,	albendazole’s	adverse	effects	after	treatment	of	porcine	
cysticercosis include prostration, anorexia, lethargy, and death after a single dose of 50mg/kg, and lethargy and 
anorexia after three consecutive doses of 30 mg/kg (Mkupasi et al., 2013). This makes it not recommended for the 
treatment of porcine cysticercosis in pigs by most manufacturers.
The drug stockists were asked to estimate the percentage of farmers that deworm in their districts and the number 
of times they deworm. They indicated that an average of 68% of farmers who own pigs deworm their pigs about 
six	times	a	year	with	a	range	of	one	to	12	times	and	most	farmers	deworming	twice	a	year.	Little	difference	existed	
between the districts in terms of the number of times dewormed and the percentage of farmers that deworm. The 
drugs stockists indicated that in Bukedea, peak
sales occur during the rainy season and low sales occur in the dry season. In Masaka, 55% indicated that there 
were no peak and low seasons, while the others indicated the same trend as in Bukedea. The reason for the high 
sales in the rainy season was that the pigs are prone to becoming infected with worms then. However, even the 
32% of druggists that don’t deworm present an opportunity for the TSOL18 vaccine-oxfendazole combination.
The estimated cost of deworming can be calculated using the number of times the farmers deworm pigs, along 
with the prices from table 17 and several assumptions:
• Farmers deworm an average of six times a year (two to three times a year being previously reported by 
the veterinarians).
• The cheapest dewormer that treats tapeworms on the market costs US$0.077 per 10-kilogram pig 
(Erafen 5), and the most expensive dewormer costs US$0.28 per 10-kilogram pig (Albafas).
These data and parameters indicate that deworming would cost a farmer between US$1.62(if the farmer 
deworms six times a year using Erafen 5) and US$6.11 (if the farmer deworms six times a year using Albafas). 
The cost can go a bit higher since the pigs gain weight and the calculation is based on a 10-kilogram pig. To 
be competitive, the TSOL18-oxfendazole combination (viewed simply as a dewormer) should be within this 
price	range.	If	demand	could	be	created	for	other	unique	features	(e.g.,	control	of	cysticercosis),	there	might	be	
additional willingness to pay.
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8.5.3 Promotion of new products
The drug stockist were asked about how they got to know about the new products on the market (table 21). 
Most drug stockists heard about new dewormers through radio, newspaper, or television advertisements (85%) 
and the distributors marketing the dewormers directly in their shops (75%). Mobile phone calls are an emerging 
communication pathway. This means that if the TSOL18-oxfendazole combination is to be promoted, it could use 
advertisements and promotion through distributors.
Table 21: Ways drug stockists learn about new products
Promotion mechanism % of drug stockists that 
access
% of vaccine stockists that 
access
Advertisements (radio, newspapers, TV) 85 60
Distributors goes door to door marketing 75 40
Distributor makes phone calls 45 20
Distributor	gives	leaflets/catalogues,	posters 35 60
Distributor conferences/seminars 15 50
Sales promotions 15 30
Internet 15 10
Other drug stockists 5 10
Becoming an agent 0 20
8.5.4 Distribution mechanisms for dewormers 
The	drug	stockists	were	asked	how	they	receive	the	drugs	and	vaccines	from	the	distributors,	shown	in	figure	
18. The drug stockists had three options: having the distributor come to their shop on a scheduled date for that 
region; calling the distributor in case of stock outages and having the drug sent through any means of transport 
they choose (with the transport costs incurred by the stockist); and going to the distributor and collecting the drugs 
themselves. In Masaka, 61.5% of the drugs and vaccines were delivered by the distributors; 31% of the drug 
stockists	collected	them	from	the	distributor.	In	Bukedea,	these	two	options	were	chosen	almost	equally.	For	all	
the districts, 44.8% of the drug stockists reported that they collect the drugs from the distributor, 37.9% have the 
distributor deliver the drugs during their routine visits and the rest send their orders for delivery to the distributors. 
The pharmaceutical companies Norbrook and Eram have the most brands on the market and could be possible 
partners in distributing the oxfendazole dewormers.
Figure 18: Participants’ reported distribution channels for drugs and vaccines
Distributor delivers to
customer



















8.5.5 Distribution mechanisms for vaccines and challenges
Stockists were also asked about vaccine suppliers. Eight companies were mentioned (table 22), although they 
distribute mostly poultry vaccines. Eram, Norbrook, and Evervictory were ranked as the most important distributors 
of	vaccines	because	of	reliability,	quality	assurance,	and	delivery	to	shops.	The	vaccine	stockists	in	Bukedea	
mentioned as a supplier ‘Container Village’, an area in Kampala where drug and vaccine importers are found. In 
Masaka, drug stockists mentioned the government typically supplies vaccines for lumpy skin disease and foot 
and	mouth	disease	(both	for	cattle);	thus,	if	a	drug	inspector	finds	them	in	a	druggist’s	stock,	they	have	to	provide	
an explanation. Other vaccines like Peste des Petits Ruminants (PPR) and those for dogs can only be ordered on 
client	request.	Generally,	for	poultry	vaccines,	the	Newcastle	disease	vaccine	is	the	most	in-demand	because	most	
poultry farmers have either experienced related economic losses or seen/heard about the severity of the disease.
Stockists	mentioned	power	shortages	(80%	of	participants)	and	expensive	equipment	(40%	of	participants)	as	
major challenges they faced. One drug stockist mentioned that the National Drug Authority has set up guidelines 
that	require	an	inverter	to	stock	vaccines	in	case	of	power	shortages	or	a	paraffin-run	refrigerator.










8.6 Willingness of service providers to sell the TSOL18 vaccine and oxfendazole
 
8.6.1 Channels to access/buy the vaccines and drugs
The veterinarians and para-veterinarians who participated in the study reported accessing the drugs within their 
localities, especially in the district’s major town. In Masaka, the veterinarians and para-veterinarians access the 
drugs from the municipality (especially in Katwe-Butego sub-county, where most drug stockists are located). There 
are few drug shops in the rural areas because of the annual charges (about UGX300,000, or US$86) and strict 




• Premises supervised by a person holding a bachelor’s degree in veterinary medicine or an animal 
husbandry	officer. 
In rural areas, drugs are mostly delivered by the veterinarians working in those areas or farmers go to towns to buy 
drugs. However, the veterinarians said farmers mostly source drugs by themselves. 
Of the municipality’s drug shops, 44% stock vaccines together with other veterinary drugs. There is no single shop 
in town that stocks only vaccines. All shops stock mostly vaccines for poultry diseases (e.g., Newcastle disease, 
infectious bronchitis, and Marek’s disease). The few vaccines stocked for other animals include the rabies vaccine 
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for cats and dogs and (in a few drug shops) lumpy skin disease vaccine in cattle. Some veterinarians (28% of the 
service providers) sourced some drugs from Kampala (about 130 kilometres from Masaka); the reason for travel 
was that drug stockists do not stock some brands needed by veterinarians. 
Table 23 lists the actors in the drug market in Masaka and Bukedea. Masaka has an estimated nine veterinarians 
with a bachelor’s degree in veterinary medicine; of these, seven are employed by the government, while the rest 
are in private practice. In Bukedea, there are three veterinarians with a bachelor’s degree in veterinary medicine, all 
working with the district’s local government.
Table 23: Actors in the drug market in Masaka and Bukedea districts
District Actor Approximate # Interviewed
Masaka Para-veterinarians 40-60 14 (28%)
Veterinarians 9 0 (0%)
Drug stockists* 14 11 (78%)
Vaccine stockists 8 8 (100%)
Bukedea Para-veterinarians 52 10 (19%)
Veterinarians 3 2 (67%)
Drug stockists 10 10 (100%)
Vaccine stockists 2 2 (100%)
*Including vaccine stockists
8.6.2 Access to information for new products in the market
Access to information on new drugs was the same in both districts, with respondents indicating they receive 
information from:
• Distributors who usually organise seminars to train veterinarians on the use of the new drugs





Summary of the findings
• Generally, dewormers are more accessible than vaccines to the veterinarians in both Masaka and Bukedea 
districts. 
• Vaccines are more accessible in Masaka versus Bukedea district. The vaccines that are more accessible are 
almost all for poultry; access to vaccines for other livestock is sporadic.
•  
The dewormers used by the veterinarians and pig farmers fall in the drug categories of ivermectins, 
levamisoles,	albendazoles,	and	piperazine	citrates.	The	veterinarians	prefer	ivermectins,	specifically	the	
brands Noromectin and Keramectin, while the farmers prefer levamisoles (preferred brand Wormcid)  
• The price range for injectable dewormers was UGX7,000 to UGX20,000 (US$2 to US$5) per bottle (of either 
50 millilitres or 100 millilitres). The range for oral dewormers was UGX200 to UGX6,000 (US$0.05 to US$2), 
with	tablets	being	cheaper	than	the	liquid	drenches. 
• More than 75% of farmers deworm their pigs two to three times a year. In both districts, the charge for 
deworming ranged from UGX2,000 to UGX5,000 (US$0.60 to US$ 1.50). 
• Most veterinarians would not deworm pigs that are not in their area of operations because it would make 
deworming	unaffordable	for	the	farmers. 
• One challenge in Bukedea was almost all vaccines being out of stock out except for the thermal stable 
Newcastle disease vaccine. 
• The para-veterinarians in Masaka were not aware of porcine cysticercosis, while those in Bukedea were 
aware of the disease. 
 
• In both districts, veterinarians would be willing to sell the TSOL18 vaccine only if the price is not more 
than	UGX3,000	(US$0.90),	the	vaccine	efficacy	is	proven,	the	disease	is	publicised,	and	the	benefits	of	
vaccination are well articulated for the farmers. 
8.6.3 Transportation of vaccines
 
In	Masaka,	veterinarians	and	para-veterinarians	use	several	types	of	equipment	when	transporting	vaccines	
depending on the distance of the farmer, number of animals, number of farmers, and errands the veterinarian 
needs	to	run	before	vaccinating.	This	equipment	include	iceboxes,	floaters,	flasks,	and	polythene	bags	(table	24);	
the	vaccine	stockist	supplies	the	ice.	This	is	the	same	equipment	used	in	Bukedea	district.	In	both	districts,	the	
veterinarians and para-veterinarians indicated that they use bags, polythene bags, and boxes for the drugs.
Table 24: Equipment used for vaccines
Equipment Reason for choice
Ice box Long distances to travel, many animals to vaccinate, few errands
Floaters Received cases when one could not access an icebox and the distance is far
Flasks Distance is short, few animals, veterinarians has just started practicing
Polythene bags Distance is very short, no errands
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8.6.4 Dewormer use by veterinary professionals and farmers
In	Masaka,	the	veterinarians	preferred	to	use	ivermectin	because	it	is	easy	to	administer	without	significant	
retraining on pigs and because it can control both external and internal parasites with minimal dosage. It is also 
very	effective	against	mange;	farmers	can	easily	see	the	effect	of	the	treatment.	Most	veterinarians	were	guarded	
on the use of injectable levamisole, especially those recommended for subcutaneous administration. This is 
because if the drug were injected intramuscularly by mistake, the pig would die in a few minutes. Veterinarians 
and	para-veterinarians	do	not	use	oral	levamisole;	they	indicated	farmers	prefer	these	because	they	don’t	require	
technical expertise to administer.
In	Bukedea,	the	veterinarians	and	para-veterinarians	said	drenches	are	cheaper	in	the	field	than	ivermectin	and	
farmers prefer oral drugs because administration is very simple. Most farmers don’t know there are injectable 
dewormers and some would not believe their pigs had been dewormed if the veterinarians used injections. In 
both districts, the veterinarians and para-veterinarians said that the farmers who self-administer dewormers to 
their pigs prefer the levamisole brand Wormcid because it is easier to use and some farmers believe that it helps 
in fattening the pigs. The veterinarians and para-veterinarians preferred brands of ivermectins called Noromectin 
and	Keramectin	because	they	use	a	lower	dosage	for	effectiveness	and	don’t	require	follow-up;	the	other	brands	
require	going	back	after	a	week	to	administer	another	dose,	making	it	expensive	for	farmers	(Table	25).
Table 25: Pig dewormers used in Masaka and Bukedea districts
Drug groups Brand names Price in UGX (pack size) Administrative method





Vermectin 10,000 (50 ml)
Levamisole Levacide 7,000 (100ml)
Levamisole injectable 7,000 (100ml)
Wormcid drench 3,000 (125ml) Oral
Wormcid tablets 200 (tablet)
Vet worm drench 3,000 (125ml)
Vet worm tablet 200 (per tablet)
Albendazole Albendazole drench 4,500 (120ml)
Albendazole tablets 500 (per tablet) Oral
Piperazine citrate Ascarzine 6,000 (per pack of 100g)
Ascalex 4,000 (per pack of 30g)
8.6.4.1	 Price,	administration,	and	frequency	of	deworming
In Masaka, the veterinarians and para-veterinarians who participated in the study charged an average price for 
deworming a pig of about UGX3,000 (US$0.90) per animal, including transport. If the farmer is very close to the 
area where the veterinarian operates, they are generally charged only UGX2,000 (US$0.60) per pig. However, the 
cost can rise to UGX5,000 to 8,000 (US$1.40 to $2.30) if the distance is far. In Bukedea, the cost of deworming 
depends	on	the	financial	status	of	the	farmer,	type	of	dewormer,	and	distance	from	the	farmer	to	the	veterinarian.	
But on average the veterinarians and para-veterinarians in Bukedea charges UGX1,000 (US$0.30) per piglet, 
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UGX2,000 (USD$0.60) per gilt, and UGX5,000 (US$1.40) for the adult pigs. If the farmer is too far, then the 
veterinarian waits to attend to that farmer until there are other cases in that area; this was also the case in Masaka.
There are three major method of administration to pigs – oral, subcutaneous, and intramuscular – with the method 
used depending on the instruction sheet that comes with the drug. In both districts, all veterinarians and para-
veterinarians	preferred	the	use	of	injectable	drugs	rather	than	oral	administration	because	pigs	are	very	difficult	
to restrain and bite syringes when receiving dewormers orally. Veterinarians and para-veterinarians normally 
recommend that farmers use the oral dewormers when self-administrating because they have a wide safe margin 
and are easy to apply. 
In Masaka, about 75% to 100% of the pig farmers deworm their pigs. Normally, the farmers deworm pigs an 
average three times a year. Those that don’t deworm use local herbs (e.g., one called ‘lusiti’). In Bukedea, farmers 
deworm two or three times a year, and the decision to deworm depends on the harvest time since this is when 
farmers have extra income to buy the drugs. In both districts, veterinarians and para-veterinarians mentioned that 
farmers normally deworm during the rainy season.
8.6.5 Willingness to sell the TSOL18 vaccine-oxfendazole package
In Masaka, all of the para-veterinarians that attended said that they had never heard of porcine cysticercosis but 
knew about the tapeworm. In Bukedea, all of the veterinarians were aware of the condition and said the region 
even has a local name, ‘ikuri’, because the disease is said to resemble a cowpea (a staple cereal in that region). 
The disease is so serious in their community that no trader would buy a diseased pig. This high level of awareness 
was	probably	due	to	a	farmer	who	had	to	refund	a	trader’s	money	because	when	the	district	veterinary	officer	
inspected the pig and found cysts, he burnt the pork. The fact that the vaccine trials with GALVmed are happening 
there could also be a contributing factor.
In Masaka, all participating service providers were willing to sell the vaccine as long as it did not cost more than 
UGX3,000 (US$0.90) to the farmer to attain immunity; this means that the drug stockists need to sell the dose 
at about UGX1,000 (US$0.30). They said that the farmers could only accommodate those prices if the vaccine’s 
value is demonstrated to them. The veterinarians preferred the vaccine packaged in 20 mL units because it would 
bring the transaction costs (for example, transport) down for deworming/vaccination 20 pigs.
In Bukedea, the veterinarians and para-veterinarians said they would be willing to sell the vaccine if it is priced 
between	UGX3,000	and	5,000	(US$0.90	to	$1.40),	the	vaccine	efficacy	is	proven,	and	it	is	accessible	and	easy	to	
store. They believe there is a market for the vaccine because the disease is common in their district. Additionally, 
farmers	in	Malera	sub-county,	where	the	vaccine	was	tested,	are	aware	of	its	benefits	in	controlling	porcine	
cysticercosis. The vaccine would lose market potential if it were priced substantially more than the dewormers. 
Veterinarians and para-veterinarians said the vaccine should not exceed UGX3,000 (US$0.90) in cost to the farmer. 
Most farmers know that vaccination is a public good that is supposed to be provided by the government at a 
subsidised price or even free of charge.
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Summary of the findings
• The most commonly distributed livestock dewormers in Uganda are albendazole, levamisole, ivermectin, and 
piperazine. 
• Most animal vaccines distributed in Uganda target cattle, poultry, shoats, and (to a lesser extent) dogs and 
cats. 
• There is no vaccine for pigs distributed in Uganda. 
• The mark-up for the distributor (in Kampala) and drug stockist (in the district) was 30%. 
• Poor	cold	chain	is	a	challenge	to	the	vaccine	quality. 
• Given its current form (cost of product and packaging) and based on their experience with livestock 
vaccines, the participating distributors said they probably would be willing to distribute the product if it were 
subsided by the government. 
• Even though oxfendazole is more expensive than competing dewormers for other parasites than cysts, there 
is an opportunity for it to capture some market share because it is a broad-spectrum dewormer on top of 
being	effective	against	porcine	cysticercosis. 
• The fact that the vaccine and dewormers are not packaged together make the combination unattractive to 
distributors	because	of	anticipated	challenges	in	acquiring	both	products	at	the	same	time	when	needed. 
• The	model	for	product	adoption	most	likely	to	be	effective	is	for	it	to	be	presented	as	a	public	good.
8.7 Potential for large drug distributors to market TSOL18 vaccine and oxfendazole
8.7.1 Pig dewormers and oxfendazole distributed in Uganda
The distributors interviewed indicated that the most commonly distributed livestock dewormers in Uganda are 
albendazole,	levamisole,	ivermectin	and	piperazine.	Specific	pig	dewormers	distributed	proportionately	are	
ivermectin (60%, mainly because it can protect against both internal and external parasites), levamisole (20%), 
and piperazine (20%). The interviewed distributors did not stock oxfendazole, but stocked a benzimidazole called 
fenbendazole	that	has	similar	effects	but	needs	multiple	doses	to	clear	cysts.	This	could	be	a	substitute	for	
oxfendazole. However, the distributors mentioned that there is a brand of oxfendazole in the registration process at 
the National Drug Authority.
8.7.2 Stocked livestock vaccines and pricing strategies
Most animal vaccines distributed in Uganda target cattle, poultry, shoats, and (to a less extent) dogs and cats. 
For cattle, distributed vaccines target contagious bovine pleuropneumonia, foot and mouth disease, brucellosis 
anthrax, and lumpy skin disease. For poultry, the most common vaccine are for  Newcastle disease, gumboro, 
infectious bronchitis, Marek’s disease, fowl typhoid and fowlpox; for dogs and cats, rabies vaccine is the most 
stocked. No vaccine is stocked for pigs by the interviewed distributors. For the poultry vaccines, most of the time 
only exotic breed are vaccinated, and the Newcastle disease vaccine is the most sold. The distributor mentioned 
that vaccines are not as marketable as the drugs, mainly because farmers prefer curative rather than preventive 
measures. Vaccines targeting diseases with a high mortality rate (e.g., Newcastle disease) get higher market share 
because	farmers	can	directly	see	the	effect	of	the	diseases	on	their	flock.
60





distributors were then introduced to the TSOL18 - oxfendazole combination and informed the distributor about 




about UGX5,000 (US$1.40), meaning the farmers would pay a total of about UGX25,000 (US$6.90) per pig. This 
imply	that	the	product	will	not	be	competitive	given	that	farmers	may	not	be	able	to	afford	it	considering	the	fact	
that their major expenditures which is in dewormers is around US$1 annually.
8.7.3 Distribution of vaccines
The typical vaccine distribution process works as follows:
• From the airport, the importer picks up vaccines packed in insulated containers with icepacks from the 
airport cold room and transports them on a non-refrigerated truck. 
• At the distributor’s warehouse, vaccines are kept in a cold room until they are sold. 
• Vaccines	are	packaged	depending	on	the	quantity	required	by	customers:	Vaccines	are	transported	in	
insulated	material	with	ice	packs	for	those	purchasing	in	bulk	quantities,	and	temperature	monitors	are	
included in the packaging so a cold chain is maintained, especially for government purchases to their 
cold	room.	Those	purchasing	individual	doses	or	less	stock	are	required	to	have	a	flask	and	ice	packs	
before vaccines are sold. 
Challenges do occur for drug stockists selling to farmers, as there is poor packaging to maintain a cold chain, 
vaccine reconstitution, and ignorance of cold chain maintenance amongst the farmers.
8.7.4 Willingness to distribute the TSOL18 vaccine-oxfendazole package
According to the distributors, vaccine uptake is generally low in livestock due to farmers’ lack of knowledge on 
vaccine	use	and	its	direct	benefits	to	the	farmer.	Its	benefits	are	more	public	health-focused,	making	the	product	
less attractive to farmers; Farmers would incur minimal loss if they do not use the proposed vaccine. In addition, 
cheaper options for eliminating tapeworms are available on the market. Given these challenges, the distributors 
would be willing to stock the vaccine if the government is involved by making it mandatory to vaccinate against 
porcine cysticercosis. This speaks to the need for integrated ‘One Health’ approach.
On the use of the TSOL18 vaccine-oxfendazole combination, the distributors mentioned that it is better if both 
products are sold together (as recommended) by the same distributor. It would also be better if the manufacturer 
packaged the dewormer in tablet form and it were administered as single dose.
8.7.5 Suggestions for distribution mechanism and uptake of the TSOL18-oxfendazole package
The interviewees discussed three strategies for a distribution mechanism of the vaccine and evaluated their 
likelihood of success:
• Strategy 1 (Low): The product is fully managed by distributors (the current mechanism). The distributor 
imports the vaccine, launches it, trains other distributors and their networks focusing on areas with 
high	pig	population,	and	uses	equipment	for	the	cold	chain	in	place	(electricity).
• Strategy 2 (Medium):	A	consumer-driven/certification	model,	with	proof	of	vaccination	certification	
presented at slaughter. In this way, vaccine uptake can be promoted via self-regulation in the market. 
• Strategy 3 (High): Vaccine as a public good, convincing the government of the human/public health 
impact (e.g., epilepsy) and ensuring farmers understand their roles in the transmission of the disease 
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and its impact on humans. A ‘One Health’ approach by the Ministry of Livestock and Health could be 
used and the vaccine subsidised by government. This strategy could involve a government initiative, 
as	with	mosquito	nets;	a	government	initiative	to	buy	vaccines	from	importers	in	bulk	would	minimise	
costs to farmers. This strategy would involve pig value chain actors and focus on areas with high pig 
densities and commercial farms. 
 
Table 26 summarises distributors’ recommendations for the TSOL18 vaccine-oxfendazole product.




• Option 1: Have the same distributor for the TSOL18 vaccine and oxfendazole.
• Option 2: Package the TSOL18 vaccine and oxfendazole together.
Dewormer • Explore if the dewormer can be formulated into a tablet form instead of drenching.
Vaccination • Use collective vaccination to reduce the transaction cost of the veterinarian.
• Consider training vaccinators.
• Consider	that	vaccine	quality	indicators	are	useful	(feedback	through	mobile	phone	is	
used in Uganda) but expensive.
National Drug 
Authority
• Organise training on how to maintain the cold chain.
Consumers • Raise awareness and educate consumers.
Distribution • Consider	that	a	monopoly	is	the	best	way	to	distribute	a	product	to	control	its	quality.	
According to one of the distributors, the East Coast fever vaccine is unattractive from a 
business	perspective	because	there	are	two	distributors	in	Uganda	and	the	profit	is	minimal.
• Streamline the competition and deploy ethical standards across all distributors. 
Companies do not have same standard operating procedures for marketing, which 
affects	product	quality	because	distributors	all	manage	the	product	their	own	way.	
Authorities must deploy standards and streamline competition.
Awareness 
channels
• Use a combination of personal contact and broadcasting to raise awareness. Personal 
contact	(e.g.,	group	meetings	with	farmers)	is	more	effective	but	expensive	and	limited	
in terms of the number of farmers reached. Broadcasting (e.g., radio) can reach more 
farmers	but	is	less	effective	because	some	farmers	do	not	have	radios.
8.8 Stakeholder meeting 
Results from the stakeholder meeting focused on describing current models for delivery and distribution of 
livestock vaccines and dewormers, as well as suggestions for improved distribution for the TSOL18-oxfendazole 
package. 
8.8.1 Vaccine distribution channels
For the TSOL18 vaccine-oxfendazole combination to cover the entire country, the distributor would need to use 
the existing distribution method, including:
• Route sales, in which the distributor would deliver oxfendazole directly to drug shops countrywide.
• Real-time delivery for the vaccine to maintain the cold chain. However, in the beginning this would be a 
challenge, since TSOL18 would be a new vaccine and thus orders likely would not be as forthcoming 




this list the drug stockists that they have worked with for a long time and that have earned their trust. They explain 
the new product to the stockists and supply it on credit (excluding vaccines that are supplied by cash-on-delivery 
basis). The distributor then checks on the drug stockist to see product performance and gain feedback. The 
distributor gives only a small amount of stock to reduce the drug spending a lot of time on the shelves. From this, 
it	can	be	deduced	that	very	few	samples	would	be	imported	in	the	first	year	of	the	TSOL18	vaccine	while	the	
product is being assessed.
8.8.2 Vaccines sold alongside other drugs in Uganda
In Uganda, only the vaccine for East Coast fever is sold alongside another drug. It is distributed by two companies 
in Uganda, Scope Vet and Eram, and is administered with oxytetracycline. The distributors sell the vaccine and the 
drug	as	different	products.	The	challenges	faced	in	distributing	the	East	Coast	fever	vaccine	include:
• To	stock	it,	one	needs	liquid	nitrogen	–	a	scarce	commodity.
• Animals need to be monitored for seven days, a disincentive for adoption. 
• Training is needed on administering the drug; few veterinarians are currently trained, which leads to low 
use.
• Since	the	East	Coast	fever	vaccine	is	live,	some	animals	might	die;	this	scares	off	farmers	from	
adopting its use and thus disincentivises it being stocked in drug shops. 
The East Coast fever vaccine’s key similarity to the TSOL18 vaccine is that it is administered alongside another 
drug. The East Coast fever vaccine is promoted independently from the drug it is administered with, although 
they are used concurrently. Also, only vaccine distribution is limited to authorized distributors; oxytetracycline is 
distributed	by	many	entities	under	different	brand	names.	This	same	strategy	could	be	adopted	for	oxfendazole	
and the TSOL18 vaccine, leaving vaccine distribution to a few distributors and letting all oxfendazole brands on the 
market be used.
Additionally, the East Coast fever vaccine demonstrates how distribution can be hampered if the vaccine has 
characteristics	that	would	affect	farmers’	adoption.	In	this	case,	all	of	the	vaccine’s	distributors	have	well-
developed distribution networks, but the vaccine has failed to penetrate the market even when there are no 
competing products and the distributors do not face any competition. From this case, the TSOL18 vaccine 
needs to look at factors that would keep farmers from vaccinating their pigs, especially in terms of the price of the 
vaccine.
8.8.3 Recommendations for large-scale, sustainable private sector distribution mechanisms
 
For large-scale distribution of the TSOL18 vaccine-oxfendazole package, the vaccine always has to be available in 
the country to limit any shortages. It would be easier to use the current system in place, real-time delivery and use 
of vaccine stockists. The challenge is that some areas have pigs but very few vaccine stockists. In such areas, the 
veterinary	practitioners	and	extension	staff	are	the	best	option	to	fill	this	role	for	farmers.	In	such	areas,	the	closest	
vaccine	stockist	is	treated	as	priority	in	distribution	(i.e.,	scheduled	first	when	they	send	in	orders).	Other	avenues	
for distribution would need to be explored, such as sending the vaccine through the courier bus services (although 
the distributor would need to educate the courier service providers on how to handle the vaccines and invest in 
coolers to transport the vaccine). For oxfendazole, the normal distribution mechanisms used for other drugs can 
be adopted (route sales).
One key challenge for TSOL18 vaccine distribution is that most of the distributors import drugs and vaccines only 
two to three times a year, so the distributor that has the contract must also have the capacity to stock enough 
vaccines. Additionally, the TSOL18 vaccine targets a disease of low economic importance to farmers, so sales 
would	not	be	very	high	–	meaning	that	the	cost	of	distributing	the	drug	would	affect	the	final	product	price	to	the	
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farmer. Another key challenge is that the vaccine industry is highly regulated, with more regulations set to take 
effect	on	the	distribution	of	vaccines.
The stakeholder meeting participants agreed that for successful distribution, there should be enough of a market 
for	the	product.	In	this	case,	the	TSOL18	vaccine	should	be	affordable	enough	to	create	farmer	demand.	This	
would make the distribution sustainable because there would be a market pull.
8.8.4 Models for product promotion
Since the TSOL18 vaccine can only be administered by professional animal health service providers and not by 
farmers, the best promotional model would be through giving seminars. Additionally, promotion posters can be 
distributed	to	the	drug	stockists,	although	they	first	need	to	be	approved	by	the	National	Drug	Authority.	
Another model for product promotion is using the traditional extension system to promote the vaccine, through 
public	extension	staff	in	each	sub-county	conducting	trainings	and	promoting	awareness	of	porcine	cysticercosis	
in their areas of jurisdiction. This would be costly but would lead to a lot of coverage in the country. Additionally, 
another suitable promotion model would be large-scale awareness-raising of porcine cysticercosis as zoonosis. 
This could be done over television and radio but would still need approval from the Ministry of Health. If this is 
done,	then	vaccine	promotion	would	be	relatively	easy.	The	challenge	is	convincing	ministry	officials	that	this	
disease	is	worth	the	effort,	which	can	only	be	done	if	ministry	officials	are	convinced	with	numbers	on	taeniasis	
cases and epilepsy due to cysts.
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9.1 Methods to support adoption of the TSOL18 vaccine-oxfendazole combination
9.1.1 Willingness to pay
The results from the market studies provide insight into the potential of marketing the porcine cysticercosis vaccine 
and dewormer as a private good. Pig farmers’ choice behaviour indicates that if the vaccine is to be marketed 
as	a	private	good,	then	the	market	would	require	a	premium	price	to	be	paid	for	vaccinated	pigs.	However,	the	
traders’ choice behaviour for porcine cysticercosis-vaccinated pigs, shows substantial preference for pigs with 
high	carcass	weight.	Furthermore,	the	premium-price	attribute	is	not	statistically	significant.	It	is	the	dewormer	
component that may result in extra weight due to a reduction in worm burden. Although the participating traders 
are concerned about consumer health, most believed that control of porcine cysticercosis is the role of the 
government and should therefore subsidise the cost of the vaccine. The perceptions of large drug distributors and 
animal health service providers match those of traders. They believe that porcine cysticercosis control should be 
promoted through a public good channel because its negative impacts are much more visible in human health than 
in animal health. Hence, there is a need to engage the government to make this vaccination mandatory.
This exercise demonstrated that farmers have a high propensity to hold onto money (high time preference and 
high discount rate) and would therefore not want to spend much money on the vaccine and costs associated 
with vaccination administration; this was demonstrated by the high willingness to pay for a vaccine with low 
administration	costs	and	low	frequency	of	administration.	Quality	assurance	was	an	important	attribute	highlighted	
by farmers and consumers alike. Farmers preferred a vaccine with a viability indicator, showing the importance of 
quality	assurance	for	the	vaccine	and	veterinary	products.	Pig	farmers	in	Uganda	have	reported	poor	performance	
for products such vaccines and dewormers, which is due to the use of adulterated products and poor handling 
and	misuse.	So	incorporating	a	quality	tracer	in	the	vaccine	would	be	of	interest	to	farmers,	would	provide	
reassurance and could improve perception and uptake. The Pan African Veterinary Vaccine Centre (AU-PANVAC) 
of	the	African	Union	provides	international	independent	quality	control	service	for	veterinary	vaccines	produced	
in	and	imported	to	Africa,	so	in	addition	to	manufacturer’s	quality	control	testing,	batches	of	the	TSOL18	vaccine	
should be submitted to AU-PANVAC to provide additional reassurance. 
Participating	consumers	of	food	from	animal	sources	raised	concerns	about	lack	of	labelling,	certification,	and	clear	




The TSOL18 vaccine-oxfendazole package has potential for market capture if the package’s price range is similar 
to conventional pig deworming. Combining the vaccine with a dewormer such as oxfendazole would make it 
slightly less favourable for the veterinarians since they dislike administering oral dewormers; oxfendazole and 
even other derivatives of benzimidazoles are not dewormers that veterinarians use in Uganda. In that regard, it 
is	important	that	the	safety,	efficacy	and	quality	benefits	of	this	brand	are	clearly	presented	to	veterinarians	and	
farmers to gain the acceptance of these important stakeholders. Mass awareness of porcine cysticercosis should 






easier, franchising for drug distribution should initially be given to just one distributor. The promotion costs should 
be	borne	by	the	manufacturer,	as	this	would	reduce	the	final	price	and	thus	potentially	improve	uptake.	Training	
extension	staff	in	pork	inspection	on	porcine	cysticercosis	would	also	promote	adoption	because	it	would	increase	
the number of reported cases and also make traders aware of the condition.
Given farmers are considered the most important customers for the vaccine-dewormer combination, alternative 
delivery mechanisms may need to be explored (e.g., via community animal health workers). Vaccines are popular 
where disease has a high economic impact; currently, the economic impact of cysticercosis is limited, and more 
incentives need to be created to encourage uptake. Animal health service providers could potentially play a role in 
growing the market.
9.1.3 Cost of the product
Reports indicate that a retail price of around US$1 per dose is an acceptable limit for smallholder farmers to 
be able to purchase the vaccine (Bardosh et al., 2014). In this study, a maximum retail price of US$0.90 per 
treatment	is	what	farmers	said	they	could	afford;	this	matches	what	they	regularly	spend	to	deworm	their	pigs	
(Bardosh et al., 2014).
9.1.4 Formulation of the vaccine
Ideally, one vaccine dose should provide lifetime protection for pigs; in many traditional pig-breeding areas where 
pigs are free-roaming, the life of a slaughter pig is about 12 months. According to Pedersen et al. (2000), this might 
be possible by using delayed- or pulse-release vaccine formulations or by using live recombinant vaccine vectors 
such as salmonella. Another option could be combining the porcine cysticercosis vaccine with  African swine fever 
vaccine (if available) since African swine fever is generally farmers’ most-feared disease causes them more direct 
losses; or a respiratory disease vaccine such as Porcine Reproductive Respiratory Syndrome (PRRS).





more than what they do for regular deworming; based on this study, the product would cost at least 10 times 
regular	deworming,	making	it	unaffordable	for	farmers.	Benefits	to	the	community	are	the	decline	and	eventual	
disappearance of T. solium	tapeworm	carriers	and,	in	the	long	term,	neurocysticercosis.	It	may	be	is	a	sufficient	
justification	for	a	government	to	fund	a	vaccination	campaign	against	T. solium cysticercosis. In this study, all the 
interviewed value chain actors and stakeholders suggested that considering the high cost of the vaccine, it should 
be considered a public good if eradication must be achieved.
9.2 Roles of sensitisation in the uptake of the product
A	study	in	Tanzania	found	that	health	education	intervention	significantly	improved	knowledge	of	and	attitudes	
towards T. solium cysticercosis control and thus would reduce the consumption of infected pork (Ngowi et 
al., 2008). It recommends that health education, particularly targeting women, be integrated as an essential 
component of prevention and control programmes for T. solium infections. Sensitisation would go a long way in 
increasing vaccine uptake, especially in areas where disease prevalence is low. All value chain actors should be 
targeted, including farmers, traders, drug stockists, animal health service providers, and public health practitioners. 
The	models	that	could	be	used	in	sensitisation	would	differ	depending	on	the	value	chain	actor:
66
• Farmers should be aware of porcine cysticercosis, its impact on pigs and public health, and how to 
control	it.	The	benefits	of	vaccination	should	be	demonstrated	to	them,	and	they	should	be	trained	
on	basic	best	practices	in	pig	husbandry	and	management	(including	pig	housing	using	affordable	
materials and feeding). Farmers should also know how and when to report a disease and have access 
to deworming regimens for their pigs.
• Traders should be aware of the disease and its impacts on human health. The role and importance of 
live	pig	inspection	should	emphasise,	and	they	should	be	trained	on	basic	tongue	palpation	techniques	
in	the	absence	of	a	qualified	veterinarian.	
• Veterinarians should be aware of the disease and control options, including vaccination. Their 
diagnostic capacities should be enhanced, especially tongue palpation, to reduce the number of 
infected pigs reaching the market. Veterinarians should be used to reach farmers given their close 
working proximity.
• Veterinary drug distributors have long been the primary drug distribution model used in Uganda, 
according to key informant interviewed during the stakeholder meetings. Because the vaccine is a 
biological and policy issue, radio and television advertisements cannot be used because they are 
banned by law. If this model is used, then the vaccine manufacturer contracts with the distributor to 
promote the vaccine. Since the TSOL18 vaccine-oxfendazole combination would be new and have no 
competing products, the distributor would be hesitant to pick up the cost. Because oxfendazole has 
some competitive advantage over other dewormers and is a single dose, the distributor could take on 
the drug’s promotion cost. 
• Public health practitioners’ training should focus on disease diagnosis since this would lead to 
improved meat inspection; any carcass rejected due to the disease would lead to more awareness 
amongst traders.
• Government/policymakers,	specifically	health	officials,	should	be	convinced	of	porcine	cysticercosis’	
importance, especially economically. This could happen through detailed studies to estimate the 
disease’s monetary impact, which could prompt funding to raise awareness of the disease and 
methods of elimination (including vaccinating pigs). This would help increase vaccine uptake and would 
reduce distributors’ costs related to sensitisation. 
 
The bundling of the two products together presents some marketing challenges. Due to government regulations 
around vaccine advertising, TSOL18 can only be advertised using seminars and targeting technical personnel. 
Oxfendazole can be advertised through radio, television, and other methods; however, if only oxfendazole is 
advertised	this	way,	it	would	have	higher	coverage	of	oxfendazole	and	would	affect	vaccine	adoption	(with	people	
opting to deworm rather than vaccinate). Given this predicament, the awareness-raising phase would need to 
be	the	first	step	undertaken	prior	to	advertisement.	Then	seminars	could	be	arranged	countrywide	for	vaccine	
promotion.
9.3 Actors’ roles in creating a cost-effective, sustainable process
 
The major actors in the drug and vaccine value chain are the manufacturer, the distributor, drug stockists, animal 
health service providers, pig farmers, and traders. The National Drug Authority, the Ministry of Agriculture, Animal 
Industries, and Fisheries, the District Veterinary Department, and extension service providers in the sub-counties 
also help create an enabling environment in terms of the value chain. For the TSOL18 vaccine-oxfendazole 
combination,	these	actors	would	all	need	to	play	a	role	to	create	a	cost-effective,	sustainable	process:
• The drug distributor would organise seminars at the district level for the drug stockists, district 
officials,	and	animal	health	service	providers.	In	these	seminars,	the	distributors	would	explain	porcine	
cysticercosis epidemiology and prevalence rates, as well as how the vaccine would reduce and 
consequently	eradicate	T. solium cysticercosis. The distributor would also talk about the pricing and 
the locations where the vaccine could be found, as well as the means of delivery. 
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• The district veterinary department could conduct district awareness campaigns for the disease 
using	their	extension	staff.	This	could	include	staff	calling	for	village	meetings	for	smallholder	farmers,	
educating them about the disease and making them aware that T. solium cysticercosis can be 
vaccinated	against	(without	mentioning	the	TSOL18	vaccine	specifically).	The	campaign’s	cost	should	
be borne by either the manufacturer or the local government if it is convinced that the disease is worth 
eliminating.
• Drug stockists would make smallholder pig farmers aware of the vaccine and T. solium cysticercosis 
through posters and educating customers that come to buy another pig-related drug. They could also 
offer	to	vaccinate	pigs	for	their	customers	as	a	service.	The	drug	distributor	must	supply	stockists	on	
time.
• Animal health service providers	are	the	most	significant	category	of	actors	in	terms	of	dealing	
directly with farmers on drug administration. They should be used to reach many farmers during 
awareness campaigns though a training-of-trainers approach. 
• Pig traders	should	be	used	as	the	change	agent	since	they	are	more	likely	to	find	T. solium 
cysticercosis	in	the	pig	when	slaughtered	and	the	economic	impact	affects	them	most	given	that	they	
cannot easily identify the disease at the point of purchase. 
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10.1 Marketing the vaccine as a private or public good
The potential for marketing the TSOL18 vaccine-oxfendazole combination as a private good is low given the status 
quo;	the	market	doesn’t	reward	food	safety.	Farmers	are	willing	to	pay	for	the	vaccine	only	if	premium	prices	are	
guaranteed, while traders’ willingness to pay premium prices is based on higher pig weight, consumers’ willingness 
to pay for safe food, and services providers’ willingness to market the product. There are several barriers to market 
entry that need to be addressed to improve the market environment:
• The	cost	of	the	product	is	high	and	must	be	significantly	reduced	if	it	is	to	be	promoted	as	a	private	
good, possibly through subsidising.
• The	intervention’s	benefits	need	to	be	made	visible	to	farmers	and	traders.
• Some	of	the	product’s	characteristics	need	to	be	revised	to	meet	the	reality	in	the	field.
• The capacities of animal health service providers need to be enhanced in diagnosis and treatment of 
the disease.
• The enabling policy environment for distributors needs to be improved.
• The impacts of porcine cysticercosis should be acknowledged and its control given momentum by the 
government.
The rising pig population and pork consumption in Uganda presents an opportunity for marketing the product, 
although porcine cysticercosis is not a priority disease to farmers like African swine fever (probably because 
economic	losses	from	African	swine	fever	are	evident	versus	from	porcine	cysticercosis).	Therefore,	significant	
awareness and sensitisation is needed to achieve impact at scale for the control of porcine cysticercosis. This 
cannot be done by farmers alone; all value chain actors and stakeholders should be involved, with a clear push by 
the government.
10.2 Marketing opportunities and barriers
About 1.1 million households rear pigs in Uganda (UBOS, 2009). The survey also indicated that 68% of pig farmers 
deworm at least twice per year. The farmers that deworm are more likely to take up the vaccine since they can 
afford	deworming,	which	would	mean	that	748,000	households	could	potentially	vaccinate	their	pigs;	districts	with	
high porcine cysticercosis prevalence would have higher penetration rates than those with low prevalence rates. 
Assuming a penetration rate of 1%, this would mean that 74,800 households would vaccinate their pigs. The 
highest market potential would be in Eastern Uganda; though the pig populations are low there compared to the 
other	regions,	the	prevalence	rate	is	high	–	making	vaccine	adoption	quite	easy	and	fast.
The market distribution structure would be based on one or two local large distributors selling to the many local 
retailers serving as drug stockists; these stockists would in turn sell the vaccine to the trained technical personnel 
(veterinarians	and	para-veterinarians)	and	sell	oxfendazole	to	the	farmers	since	these	are	packaged	as	different	
products. The vaccine has no competing products since the disease is not vaccinated against in Uganda, but 
the dewormer oxfendazole has competing products – Wormcid, a levamisole, has the largest market share in 
deworming pigs, followed by the ivermectins used by the technical personnel for deworming; there is also a 
fenbendazole (Erafen 5) on the market that competes directly with oxfendazole since it targets tapeworm and 
can be used in deworming pigs. Even though fenbendazole is on the market, it is still a new product and can be 
outcompeted	by	oxfendazole	since	the	former	requires	several	doses.
 
The major market segment for the porcine cysticercosis vaccine would be veterinarians and para-veterinarians. If 
10. Recommendations
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they are convinced by the results of the vaccine, then the farmers would adopt it since most farmers rely heavily 
on these professionals for any uptake of new products. To a lesser extent, if the government is convinced that 
the disease is critical, then they could also be potential customers; for example, for diseases like foot and mouth 
disease, the major customer is the government.
10.2.1 Market entry points
The	value	proposition	of	the	porcine	cysticercosis	vaccine	is	more	tailored	to	public	health	benefits	rather	than	
economic	benefits,	with	the	deworming	component	giving	it	economic	benefits.	Thus,	the	vaccine	needs	to	be	
sold as a product solving a public health need. This would mean that there is a need to demonstrate porcine 
cysticercosis’ correlation with cases of epilepsy in humans in Uganda to attract policymakers. In the meantime, 
since deworming is an acceptable and routine animal husbandry practice, the value proposition could focus on 
reducing	deworming	times	(though	the	vaccine	only	fights	one	type	of	worm).	Another	(improbable)	idea	is	to	
encourage manufacturers to develop multi vaccines as they do for shoats/ cattle and poultry so there is added 
value in vaccinating against more than one disease; for this, it would be imperative to rely on the private sector 
since the bulk of veterinary vaccination is through this sector, which has an established distribution mechanism.
10.2.2 Barriers to market entry
Some	distributors	in	Uganda	have	exclusive	agreements	to	distribute	specific	products	from	manufacturers.	This	
type	of	agreement	would	be	difficult	to	use	in	terms	of	the	TSOL	vaccine-oxfendazole	combination,	and	some	
of these distributors have well-established sales routes and market share. The National Drug Authority has strict 
guidelines for registering vaccines that can sometimes be cumbersome. Additionally, farmers’ poor attitude 
towards vaccination is one of the biggest barriers to entry. This can be easily demonstrated with the free rabies 
vaccines that are also not easily taken up by farmers. Farmers are more used to deworming their pigs, and it is a 
cheaper option compared to the TSOL18 vaccine, meaning farmers might not use the vaccine since its price is far 
too high compared to conventional dewormers.
10.3 Sensitisation approaches and materials needed
Sensitisation would target several audiences, and for each, sensitisation would be about the disease or the 
vaccine. Due to policy restrictions, sensitisation via radio and television should focus on disease awareness 
without promoting the vaccine. Meetings with the technical professionals should provide concrete evidence that 
due diligence was done in the trials and also present a safety surveillance system that is going to be used. The 
promotion of the TSOL18 vaccine and oxfendazole would be at the district level with technical personnel from 
the drug stockists and public and private veterinarians operating within the district. Additionally, pig traders are 
important	change	agents	since	they	buy	the	vaccinated	pigs.	Proper	training	on	the	effects	of	the	disease	and	its	
impact on their sales will increase vaccine uptake amongst farmers (Table 27).
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Table 27: Different sensitisation approaches for stakeholders
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of the disease 
transmission cycle 
in local languages, 
illustrations 
(photos of the 
disease)
Use of village 
meetings, radio and 
TV messages
10.4 Key opportunities and challenges
Key opportunities for the TSOL18 vaccine-oxfendazole combination in Uganda include:
• Pig population density is highest in East Africa, so there is market demand for the product.
• TSOL18	is	the	first	vaccine	for	pigs	in	Uganda,	which	gives	it	an	edge	in	the	untapped	market	of	pig	
vaccines in Uganda.
• There is a fairly developed distribution network, so the manufacturer doesn’t need to develop a new 
network.
• There are areas with high porcine cysticercosis prevalence rates (above 20%), such as Moyo, Kayunga, 
Kaliro, Kayunga, Kiberamaido, Apac, and Amolator.
• Consumption of pork is increasing in Uganda, as is the income of the population, so related food safety 
issues are increasingly important to consumers. Because porcine cysticercosis is a food safety issue, 
there is a good platform for vaccination campaigns.
• Neurocysticercosis exists in Uganda, and the government has recognised it as a serious disease, yet 
the role of porcine cysticercosis is not yet fully appreciated.
• There is willingness amongst pig value chain actors to combat the disease.
Challenges for the TSOL18 vaccine-oxfendazole combination in Uganda include:
• Diagnosis	of	the	disease	in	pigs	is	difficult	because	only	post-mortem	examination	can	give	the	best	
results. This leads to cases being common at places of slaughter without the consumer’s knowledge. 
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This means that farmers cannot be aware of the condition in their herds. Thus, pen-side diagnostic 
tests should be made available.
• Poor meat inspection leads to fewer carcasses being condemned, which in turn leads to 
underestimation	of	the	disease	burden	and	to	traders	not	regarding	the	disease	as	significant.
• The policy that vaccination can only be carried out by veterinarians is challenging in terms of increased 
transaction costs and limited coverage of veterinarians.
• The	cost	of	the	vaccine	is	high,	which	makes	it	challenging	for	farmers.	A	new	affordable	vaccine	
formulation should be researched.
10.5 Key interventions to improve livelihoods for resource-limited stakeholders
 
The key related intervention that can improve resource-limited stakeholders’ livelihoods is organised group 
vaccination campaigns. The veterinary practitioner could organise to vaccination for 20 households with one pig 
providing	schedules	and	notifications	that	there	will	be	vaccination.	This	would	reduce	transport	costs	that	would	
have been incurred by a single household. Also, involvement of communities in the control of porcine cysticercosis 
is key. This could be done through the creation of community trainers using a human health platform (such as with 
community control of malaria). 
10.6 Relevant policy issues that enhance or hamper TSOL18 vaccine delivery
Existing	policy	issues	do	not	just	affect	the	TSOL18	vaccine,	but	all	veterinary	vaccines.	The	new	proposed	
requirements	for	prequalifying	drug	shops	that	stock	vaccines	will	reduce	the	number	of	available	drug	stockists	
to distribute the vaccines and thus reduce coverage. There is also a new policy that veterinary drugs have to be 
tested and assign a new expiry date every three years; this would lead to increased costs to the distributor.
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Annex 1: Distribution of 90% of the pig population per district (UBOS, 2009)
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Annex 2: Prevalence studies on porcine cysticercosis in Uganda
District Prevalence 
(%)
Test Risk factor(s) Reference
Moyo 37.7 Post-mortem (slaughter 
slabs)
- UBOS, 2009
Kampala 9.4 Post-mortem (Wambizzi 
abbatoir)
- (Anyanzo, 1999)
Kamuli/Kaliro 8.5 B158/B60 Ag-Elisa Absence of pit latrines Kisakye and 
Masaba, 2002)
Oyam 9.4 Tongue examination Free range (Waiswa et al., 2009)
Apac 7.7 Tongue examination -
Amolator 8.2 Tongue examination -
Kaberamaido 6.9 Tongue examination -
Kamuli 12.9 Tongue examination -
Kaliro 4.1 Tongue examination -
Arua 27 - -
Busia 11 - -
Kibale 14.2 - - (Nsadha et al., 2010)
Masaka 15 - -
Kayoga 21.5 HP10 Ag-Elisa Free range (Nsadha et al., 2011)
Kaliro 23.2 HP10 Ag-Elisa Free range
Kiberamaido 20.3 HP10 Ag-Elisa Free range
Apac 28.1 HP10 Ag-Elisa Free range
Amolator 33.9 HP10 Ag-Elisa Free range
Soroti 18.0 HP10/B158/B60 Ag-Elisa Free range; absence of pit 
latrines
(Nsadha et al., 2014)
Masaka 11.7 HP10/B158/B60 Ag-Elisa Absence of toilet; lack of 
knowledge
(Kungu et al., 2017)
Mukono 11.2 HP10/B158/B60 Ag-Elisa Absence of toilet; lack of 
knowledge
Kamuli 13.5 HP10/B158/B60 Ag-Elisa Absence of toilet; lack of 
knowledge
Lira 6.9 HP10 Ag-Elisa (Kungu et al., 2019)
Moyo 13.2 HP10 Ag-Elisa
Moyo 37.7 Post-mortem (slaughter 
slabs)
- (Kungu et al., 2017c)
Kampala 9.4 Post-mortem (Wambizzi 
abbatoir)
- (Anyanzo, 1999)




set to survey respondents - pig farmers
Annex 4: Questionnaire covered socioeconomic aspects such as location of the farm and other household and 
farm level characteristics
Annex 5: Questionnaire on pig farmer’s willingness to pay for porcine cysticercosis vaccine (TSOL 18 vaccine-
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Annex 6: Questionnaire on Uganda pig traders willingness to pay for porcine cysticercosis vaccinated pigs
Annex 7: Guideline for Focus Group Discussion on Uganda consumers’ perceptions on animal source foods 
safety
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